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The name "retinoids" has come to symbolize both the natural forms of vitamin A (1) 
and derivatives 2-7 as well as modified synthetic analogues 8-26 regardless of biological 
activity or the lack of it. Actually, "vitamin A" is used as a generic term for related 
structures [except for carotenoids like ~-carotene (27)] which exhibit, at least qualitatively, 
the biological activity of vitamin A or, more appropriately, retinol (1). Vitamin A (1) and 
closely related analogues, which have 20-carbon diterpene structures, were originally 
isolated from fish liver oils, visceral parts of fish, eggs, animal kidney, lungs, eyes, and 
intestinal mucosa.29 These molecular systems bear a formal relationship to carotenes like 
27.107 Discovered in 1913,70 vitamin A (1) was initially labeled as "Fat-Soluble A" to 
distinguish it from essential water-soluble nutrients known as "Water-Soluble B".40 A fat-
soluble ingredient extracted from butter and egg yolk was able to maintain growth in rats 
and prevented xerophthalmia and night blindness. 40 Some controversy arose when Euler 
and co-workers found that carotene (27) from plants was totally different from vitamin A 
(1). Polyene 27 had different stability and chemical properties than vitamin A (1) the 
former was effective at a daily dose of about 5 J.l.g in curing the symptoms of vitamin A 
deficiency.22 Later, CapperlO and Moore75, 76 demonstrated the appearance of vitamin A 
(1) in the liver of vitamin A-deficient rats which had been given ~-carotene (27). Karrer 
and co-workers established the structure of 27 in 1930.55 Holmes and Corbet crystallized 
vitamin A (1) that had been isolated from fish liver.48 Chemical synthesis was achieved by 
Isler and co-workers.50 The first natural occurring cis isomer of the basic retinoid family 
identified was 13-cis-retinol (2) which was isolated by Robeson and Baxter in 1945.98,99 
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Initially, it proved difficult to detect a difference in tumor production in rats with a 
normal diet and those fed a vitamin A-deficient diet.32, 112 As reviewed by Frolik and 
Roller,32 in 1926 Fujimaki,38 recognized that a relationship existed between a vitamin A-
deficient diet and greater susceptibility to the formation of carcinomas. 32 Research by 
Lasnitzki showed that the premalignant phenotype of mouse prostate glands, which had 
been treated with a chemical carcinogen, could be altered by addition of vitamin A (1).59 
More than 50% of the primary cancers found in humans occur in epithelial tissue which 
depends upon retinoids for cell differentiation and growth. lOS Epithelial tissue forms a 
coating or boundary on the internal and external surfaces of organs such as bronchii, blood 
vessels, skin, etc. Such tissues are mainly composed of closely packed columnar cells 
which have very little intracellular space. 78 Many of these tissues are cilliated and most 
secrete mucus. The dependency upon natural retinoids for cell differentiation and 
maintenance of the epithelia has been known for many years and was recently reviewed. 42, 
125 
Aykroydl mentioned that, Egyptian documents revealed the use of liver, which had a 
high content of vitamin A, as a treatment for night blindness.77 In 1935, Waldreported the 
importance of vitamin A aldehyde or retinal (4) in vision. Moreover, he demonstrated that 
rhodopsin is composed of the protein opsin covalently bound to 11-cis-retinal (7b ). The 
latter plays a very important role in the visual cycle.122 Primary vitamin A deficiency in the 
liver results from inadequate dietary intake. Xerophthalmia results from insufficient retinol 
(1) to generate rhodopsin. Such a situation can occur at any age but appears to be more 
prevalent in young children, especially the form of the disease which can blind or be 
fatal.119 
Another symptom of vitamin A deficiency is the abnormal keratinization of epithelia of 
the lungs, trachea, skin, gastrointestinal tract, and urinary tract) For example, in rats a 
normal epithelium of the trachea consists of cells all of which have cilia pointing into the 
lumen. Within a few weeks, crowding and disarrangement of the epithelial cells occurs 
7 
because of vitamin A deficiency. In certain cases, cilia can be absent entirely.78 After a 
few more weeks, squamous metaplasia can be observed in which flattened, stratified cells 
replace the original columnar arrangement of epithelial cells.78 Use of an in vitro system 
demonstrated the ability of retinoids to reverse hyperplastic and anaplastic epithelial lesions 
commonly found after exposure of the tissue to chemical carcinogens.33 Furthermore, 
others have shown that certain retinoids, rather than preventing carcinogenesis, can modify 
neoplastic states of cells during a latent period before the onset of an invasive 
malignancy)05, 106 
Apart from the utility of natural retinoids as antineoplastic agents, suprisingly such 
retinoids may exhibit an acute systemic toxicity referred to as "Hypervitaminosis A" ,104 
Eskimos and arctic travelers who consumed polar bear meat or seal liver frequently 
experienced severe illness as a result of hypervitaminosis A)01 In 1979, retinol poisoning 
was reported in fishermen who had ingested 20-300 g of fried halibut liver. 81 Symptoms 
such as dizziness, nausea, vomiting, etc. were observed, but recovery was common within 
a few weeks. 54, 81 Severe toxic effects from ingestion of large doses of retinoids over 
long periods include faulty formation of keratin in epithelial tissue, softening and fracture 
of the bones, hemorrhaging, and thickening of the skin. 53, 78, 79 As reviewed by Kamm 
and co-workers, most characteristic symptoms of chronic hypervitaminosis A in laboratory 
animals have been weight loss, anorexia, emaciation, anemia, cachexia, and finally 
death. 53 Macapinlac and Olson noted that young monkeys given single lethal doses of 
retinyl acetate (5) became progressively weak, had difficulty in breathing, lapsed into 
comas, and lost simple reflex action. 67 
Vitamin A (1) is mobilized from liver stores and carried to peripheral tissues by a 
highly regulated transport system. Evidence is available that suggests the system involves 
two plasma proteins, namely retinol-binding protein (RBP) and transthyretin.41, 103 In 
plasma, vitamin A (1) normally circulates while bound specifically to RBP (Figure 1).102 
RBP in turn forms a protein-protein complex with transthyretin.102 These proteins play an 
8 
important role in transporting vitamin A (1) from the liver to the tissues. Retinol deficiency 
specifically blocks the secretion of RBP so that the level of plasma RBP falls while the 
level of RBP in the liver rises. Studies in which retinol (1) was injected into vitamin A-
deficient rats revealed a rapid secretion of RBP from the liver into plasma.102 Cytotoxic 
symptoms appeared if the level of retinol (1) reached a concentration such that it could 
circulate in the plasma unbound to RBP. This cytotoxicity was also probably due, in part, 
to excessive levels of other retinoids which were also not bound to RBP in the plasma.l3, 
102 
Recent treatises86, 108 discuss retinoid involvement in the maintenance of normal 
epithelium in tissues such as skin, mammary glands, lungs, the colon, and the bladder. 
Some investigations into the effects of retinoids on human tumors have focused upon 
various skin abnormalities because of both the accessibility of the skin and the greater 
safety of topical treatment.108 Several groups have reported that vitamin A (1) could be 
used in the treatment of Darier's disease (keratosis follicularis).79, 90,91 Retinal (4) has 
proven effective in treating actinic and non-actinic keratosis at concentrations between 0.05 
and 1.00 weight percent in 95% ethanol or propylene glycoi.126 The overall effectiveness 
of this retinoid has been at least 50%. 
Tretinoin (6) is probably the most effective topical agent in the treatment and 
prophylaxis of comedonal and inflammatory acne. 85 The agent reverses the primary event 
(abnormal follicular keratinization) in the pathogenesis of acne and prevents the formation 
of new comedones by increasing epithelial cell turnovers and reducing the cohesiveness of 
horny cells.49 Lewis, in a recent review, reported that Etretinate (8) is extensively used in 
Europe and may become the agent of choice for severe cystic acne in topical treatment while 
isotretinoin [3,13-cis-retinoic acid] is used for oral treatment.61, 62, 118 Marked therapeutic 
effects with prolonged remission of severe cystic acne were reported with oral isotretinoin 
(3) at 2 mglk:g/day (or less). 51, 62, 92 The mechanism of the drug action is not evident, but 
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Figure 1. Processes Involved in Vitamin A Transport and Delivery 
9 
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its therapeutic effect on severe cystic acne has been associated with a marked inhibition of 
sebum production.llO 
In laboratory animals, high doses of retinoids have led to embryotoxic and teratogenic 
effects (for recent review see 39). Retinoic acid (6) influences various morphogenetic 
systems such as the central nervous system, facial and palatal development, and the axial 
skeleton.57 The relationship between cancer and vitamin A-deficiency observed by 
Fujmaki,32, 38 led various scientists to postulate an essential role of vitamin A (1) in 
pathogenesis and treatment of cutaneous disorders characterized by disturbances of 
keratinization such as ichthyosis. 95 
Natural versus Synthetic Retinoids 
The toxicity of the natural retinoids must be overcome before they can be used as tumor 
preventing agents in humans. An additional problem also is that retinoid distribution in 
vivo is very modest. In contrast to dietary retinoic acid (6) natural retinoids such as retinol 
(1), retinal (4}, and esters like 14 accumulate in the liver and do not promote a dose-
dependent increase in vitamin A levels in the plasma.34 Consequently, numerous 
chemically modified retinoids have been synthesized and screened for influence on cell 
growth, differentiation, and anticancer activity. Thus, the strategy for retinoid modification 
must consider the above action as well as an influence on the vision cycle and the general 
toxicity and specificity of action. A degree of separation of properties has been observed in 
that rats with a vitamin A-deficient diet supplemented with retinoic acid ( 6) grew normally 
but could not maintain a normal visual cycle.20 Moreover, the separation of 
anticarcinogenic qualities from an influence on growth has been suggested by some 
experiments. 60 
There are several methods to examine the activity of modified retinoids. The ornithine 
decarboxylase (ODC) assay involves the following prot~oi.l21 Three sets of mice with 
two mice per set had their dorsal skin shaved 3-4 days before the experiment, and only 
11 
those mice which did not show regrowth of hair were used.121 Selected test retinoids and 







(total volume ca 0.2 mL). These solutions were applied to the shaven backs of the mice. 
Control mice were treated with the same volume of acetone and TP A. After a specified 
amount of time, the mice are sacrificed, and the epidermis is separated by a brief heat 
treatment. The tissues are homogenized in 50 mM sodium phosphate buffer (pH= 7.2) 
containing 0.1 mM pyridoxal phosphate and 0.1 mM EDTA and then are centrifuged. 
Ornithine decarboxylase activity of the soluble epidermal extracts is determined by 
measuring the release of C02 from 14C-labelled ornithine in nmole/30 minlmg of protein. 
From this value, the percent of inhibition can be calculated.121 
In a second method, certain cultured cell lines, such as murine F-9 or ~-60 human 
leukemia cells, are induced to mature in vitro via treatment with one or more of a wide 
variety of agents such as dimethyl sulfoxide (DMSO).lll The F-9 assay is based upon the 
ability of a retinoid to induce differentiation of tetracarcinoma stem cells to yield cells which 
lZ 
resemble parietal endoderm.. Ill This assay measures the activity of a plasminogen activator 
which is used as a marker for differentiation. The HL-60 assay is based on the ability of 
retinoids to induce terminal differentiation of leukemic promyelocytes to cells having many 
of the morphological and functional characteristics of normal mature granulocytes. Ill In 
practice, the assay measures the ability of cells to reduce nitroblue tetrazolium (NBT see 
page 72) as a marker for differentiation.lll 
Until now, many analogues of vitamin A (1) have been synthesized but only a few of 
them have reached the stage of in vitro testing for ability to inhibit tumor promotion by 
carcinogens. These compounds include 13-cis-retinoic acid (3), the aromatic series of 
retinoids 9, 10, amine 11, arnides 12 and 13, and the ether analogue 28 of retinol (1). 
The synthetic analogue most extensively investigated is the 13-cis-acid 3. Although this 
acid has lower toxicity than all trans-retinoic acid (6) in both mice and rats, it has not 
provided additional protection against 3-methylcholanthrene-induced lung cancer)4, 46, 47, 
82 
As described previously, several other analogues of retinoic acid ( 6) have been used to 
prevent cancer such as N-( 4-hydroxyphenyl)-all-trans retinarnide (13) which is an effective 
agent for the inhibition of breast cancer in rats. 74 Although this amide was less active than 
retiny1 acetate (5) in test systems, its lower toxicity makes it a potentially superior 
chemopreventing agent 35, 74 
Another group (8-10, 18-26) of synthetic retinoids investigated might be classified as 
arotinoids and contain aromatic systems. 64 The aromatic ester analogue 8 is more active 
and slightly less toxic than all-trans-retinoic acid (6) in retarding the growth of papillomas 
and reducing the incidence of the skin carcinoma induced in mice by 7-12-
dirnethylbenz[a]anthracene and croton oi1.4 The aromatic acid 9, of ester 8, and the amide 
10 inhibited tumor growth and, at sufficiently high concentrations, caused regression of 
established turnors.117 13-cis-Retinoic acid (3) is also effective in this chondrosarcoma 
system.117 
13 
There are three regions in the vitamin A (1) molecule which might be modified (Figure 
3). Retinoids have been reported with polar end modifications, ring modifications, and 
side chain alterations (Tables I-IV).83 Several assays have been used to determine activity 
of such modified retinoids. The effective dose at which 50% reversal of keratinization 
occurs in the hamster tracheal organ culture (TOC) assay is 5 x lQ-10 M for ethyl retinoate 
(14) (Table m and 2 X lQ-9 M for amide 1283 (see Table Ill). Retinoid 16 was 100% 
active in the tracheal organ culture assay at lQ-9 M while trans-retinoic acid (6) was less 
active (88.4%) at the same concentration.124 Thus the nature of the terminal polar group is 







Figure 3. Regions of Vitamin A (1) 
There are a few known examples in which the hydrocarbon chain of retinol (1) or 
retinoic acid (6) has been modified. For example, retinoic acid (6) has an ED 50 of 3 x 
10-11 M as compared to the ether analogue 28 which has an ED50 of 3 x lQ-9 M. 
Biological activity of other modified retinoids are found in Tables I-IV. 
The arotinoids (like 8-10, 17-26) belong to a new class of retinoids whose chemical 
structure contains one or more aromatic rings and which appear to be somewhat 
peripherally related to vitamin A (1). However, ester 17 is active in animal models at 
dosages 500 times lower than those of Etretinate (8) but possesses an identical therapeutic 
TABLE I 









*ED 5o is the minimum effective dose required to reverse keratinization in half of the test 
group. 
+Standard used. 
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BIOLOGICAL ACTIVITY OF NATURAL RETINOIDS AND TERMINAL GROUP 
MODIFIED RETINOJDS83 
Retinoid ED50,M* 
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TABLE N (Continued) 
Retinoid ED50,M* 
COzH 
3 X 10-12 
Z6 
COzH 




*ED so is the molarity of retinoid required to effect reversal of keratinization in 50% of the 
culture. 
zz 
index <EDso = 2 x lQ-8).5, 6, 7, 104 Results obtained by Ott and co-workers in seventeen 
patients with severe psoriasis receiving a dose of only 1 l!glkg/day of ester 18 showed a 
slightly better therapeutic usefulness of 18 compared to 8.1· 87 
It was also discovered that the spatial arrangement of groups can dramatically increase 
or decrease the biological activity of a test retinoid17 For example, ester 18, which has the 
(E)-configuration at the double bond, is the most active retinoid while the corresponding 
(Z)-isomer 23 is devoid of any biological activity in the papilloma system.64 In acid 19 
with a carboxyl function at the para position, the EDso = 3 x l0-7, but if this function is 
changed to the meta position (as in 20), the ability to induce differentiation in the .HL-60 
system drops dramatically (ED50 > 1.0 x l0-6).111 
Recent work from our laboratory123 as well as from Dawson and co-workers18 
reported the synthesis and biological activity of the chroman 21 and the thiochroman 22, 
heterocylic analogues of acid 19 in which the geminal dimethyl-substituted benzylic group 
at the !-position of tetrahydronaphthalene ring has been replaced by oxygen and sulfur, 
respectively. The 11,12,13,14-diene portion of the system was retained in a cisoid 
conformation by the incorporation of a phenyl ring in both 21 and 22 at the appropriate 
positions. Heterocyclic acids 21 and 22 were only slightly less active than acids 6 and 19 
in both the TOC and the ODC assays.18 The thiochroman acid 22 was far more active than 
the more polar chroman acid 21 in the TOC assay.18 Retinoid 19 was reported to be a 
most toxic retinoid.l8 Interestingly, the heterocyclic analogues 21 and 22 were less toxic 
than retinoic acid (6) and acid 26 in the tracheal organ culture assay. 
More recently two C(S)-azido substituted aromatic retinoids 24 and 25 were evaluated 
as photoaffinity probes for studying the mechanism of retinoid action. 68 Both azide 
systems, upon photolysis, became covalently bound to cellular retinoic acid-binding 
protein (CRABP).68 However, the secondary azide 24 was twice as efficient as 25, 
presumably because of less steric hindrance at C-N3. Both azides had the same activity in 
Z3 
stimulating F-9 cell differentiation as compared to the C(5)-geminal-dimethyl analogue 
26.68 
A comparison of a few active retinoids has been made in terms of effectiveness in 
reversing keratinization in organ cultures as correlated with ability to compete for cellular 
retinoic acid binding protein sites.73 However, results indicated that a correlation between 
retinoid binding activity and biological activity was not entirely as expected. Acid 26 was 
an active retinoid and competed more effectively for the binding protein than sulfur 
analogue 22.73 Consequently, the presence of the naphthalene ring versus the phenyl ring 
near the chain terminus has an influence on activity. 
Metabolites of Retinol (1), Retinal (4), Retinoic Acid (6), 
There have been numerous reports concerning the metabolism of synthetic retinoids and 
natural retinoids.20, 24, 121, 127 Many studies have concentrated on determining the 
structure of the final physiologically active form derived from retinol ( 1) which is involved 
in performing functions such as in vision, reproduction, and cell differentiation. However, 
it is still not clear what derivative is responsible for other biological functions. A possible 
scheme which relates retinol and its metabolites with activity is shown in Figure 4.89 It has 
been shown by many investigators that retinoic acid (6) acts within cells to support growth, 
but it is unable to fulfill the function of retinol (1) in maintaining reproduction and the 
visual cycle.20, 114, 115 Conversion of retinol (1) to retinal (4) and retinoic acid (5) is still 
a topic of intensive investigation.24 
In the retina of the eye, retinol (1) is oxidized to retinal ( 4) by the enzyme retinol 
dehydrogenase, 122 and retinal (4) then performs a specific function in the vision 
process.122 In other tissues, however, the complete metabolic fate of retinol (1) is 
unknown. As reviewed by Aszalos, several scientist have found that retinoic acid ( 6) is a 
documented metabolite of retinol (1) or of the ester S in several tissues of rats. 30 When a 













Figure 4. Interconversion and Biological Importance of Natural Retinoids 
2.5 
appeared and was characterized as retinyl glucuronic acid (41a).63 The proposed 
metabolic pathways for retinol (1), retinal (4), and ~-carotene (27) are shown in Figure 5. 
One other function of retinol (1), or its metabolite, is apparently to participate in a 
glycosyl transfer reaction.69 Retinyl phosphate (42) was found in rat liver and may act as 
a carrier in the transfer of sugar moieties from nucleotide sugars to the growing 














Extensive studies were reported in recent years for metabolites of retinoic acid (6) 
which would be more active than the parent compound)! Several investigations 
established certain metabolic profiles by using radioactively labeled substrates.45, 71, 96 
These results suggest that retinoic acid (6) is rapidly cleared from the body and, in some 
cases, decarboxylation occurs. 45, 96 Recently, the structures of several urinary metabolites 
were determined which included the four metabolites 43-46 from rats and humans.96 In 
addition, urinary metabolites 47-49 were isolated from rats given an intraportal injection of 





















































and 51 in addition to unchanged retinoic acid (6).44 Administration of retinoic acid (6) to 
vitamin A-deficient rats permitted the isolation of 5,6-epoxyretinoic acid (52) from 
intestinal mucosa of these animals.71 Earlier investigators had reported the isolation of a 
significant amount of 13-cis-retinoic acid (3) from the liver of rats fed with large doses of 
the all-trans-isomer (6).128 Among the biliary metabolites was retinoyl p-glucuronic acid 
(41b) which could be identified after intraportal injection ofretinoic acid (6).21 
In vitro metabolism ofretinoic acid (6) has been studied using either a hamster tracheal 
organ culture or a hamster liver cell-free system. From these systems, two metabolites of 
retinoic acid (6) were isolated, namely 4-oxo and 4-hydroxy analogues (45 and 53). 
These acids were found to be less active than all-trans-retinoic acid (6) in the TOC assay.28 
Apparently, metabolism at C(4) in acid 6 may be the initial step in one of the elimination 
pathways for retinoic acid (6) in the human body.72. 100 Epoxidation of retinoic acid (6) at 
the 5,6-position has occurred to fonn 5,6-epoxy-5,6 dihydroretinoic acid (52). Epoxide 
52 has been isolated from the intestinal mucosa of vitamin A-deficient rats which were 
subsequently given retinoic acid (6).71 It was suggested that epoxide 52 had greater 
biological activity than the parent acid 6.37 Because chain metabolites with a shortened 
side chain have been isolated, it has been suggested that retinoic acid (6) might undergo 
decarboxylation as had been shown to occur in a system treated with horseradish 
peroxidase and from which was isolated a 4-oxo-C19 aldehyde 54.100 The origin of 54 is 






Several metabolites of retinoic acid (6) were discovered from target tissues such as the 
intestine. SO Some metabolites possess biological activity similar to that of acid 6 in tracheal 
epithelial organ culture. 80 Isolation and characterization of a metabolite from intestinal 
tissue showed it to be 5,8-oxyretinoic acid (55).19 However, during the isolation, an acid-
base procedure was used for purification which may allow 5,8-oxyretinoic acid (55) to be 
formed from the known rat metabolite19 5,6-epoxyretinoic acid (47). The isolation 
procedure likely produces 5,8-oxyretinoic acid (55), as an artifact, 80 but this is a tentative 
assumption. The biological activity of 5,6-epoxyretinoic acid (52) is not well understood 
in humans. Some studies have involved oral administration of acid 52 which is converted 
to 5,8-oxyretinoic acid (55) after exposure of 52 to acid of the stomach. Converted acid 
55 is less active than retinoic acid (6) in variety of tests106 with rat fibroblast cells and 
murine melanoma cells. 
Apart from the metabolic studies of natural retinoids, several synthetic retinoids have 
been examined but the results lack an in depth analysis. 10, 52 Examples of investigations 
include the hydrolysis of retinoic acid anhydride to retinoic acid (6) in rats,94 the 
metabolism of retinaldehyde hydrazone and N-acetylretinylamine to form retinol (1)97 and 
many others.52, 116 
The most extensively studied synthetic retinoids for their metabolic activity are 13-cis-
retinoic acid (3), anude 13, and ester 8.25 The metabolism of 13- cis-retinoic acid (3) was 
examined in the hamster, the rat, and in humans. In the hamster, 13-cis-4-oxoretinoic acid 
(56) was detected in the plasma 2 hours after an intravenous dose (5.3 JJ.g) of 3H-labeled 
13-cis-retinoic acid (3). 36 In rats, intravenous administration of acid 3 showed 69% of the 
dose in the bile after 24 hours while 9% was in urine.25 This suggested that acid 3 and its 
31 
metabolites were rapidly eliminated from the body and that the major route of excretion was 
via the bile.25 One of the metabolites analyzed showed the presence of the cis-ether 57 (an 
analogue of 41a). In humans, the metabolism of 13-cis-retinoic acid (3) revealed 13-cis-4-
oxo acid 56 as the major metabolite in blood.120 
A second synthetic retinoid which has been studied extensively is Etretinate (8). Most 
of the metabolites (58a-58g) isolated from human urine after administration of (8) contain 
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One other synthetic retinoid which has been investigated to some extent is amide 13.1 13 
When a single intravenous dose (5 mg/kg) of 3H-labeled amide 13 was given to rats, 64% 
of the label appeared in feces after 5 days and 13% in urine)13 Less than 2% of these 
excreted compounds appeared as the unchanged retinoid 13. Only one metabolite 59b was 
identified in the bile of rats, other than few other minor polar metabolites.l13 After 24 
hours of intravenous dosages of amide 13, two tissue metabolites were isolated and 
identified. One was long-chain N-(4-hydroxyphenyl)retinamide fatty acid ester 59a and 
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From various biological studies, as well as from limited human trials, it is clear that 
future research might well focus upon synthetic retinoids as potentially more useful than 
natural retinoids. One goal of our research was to find an effective but less toxic synthetic 
retinoid that might display a high degree of tissue specificity for protection against cancer. 
However, actual toxicity studies would have to come at a later date in cooperation with a 
testing frrm.. 
CHAPTER II 
RESULTS AND DISCUSSION 
In recent years, several synthetic retinoids have been made, some of which do not 
support growth in experimental animals but which nevertheless have activity in preventing 
cancer and/or have the ability to control cell differentiation.13 The toxicity of retinoids, 
however, is the main limitation to their practical use. Ideally a modified retinoid suitable 
for·clinical use should be at least as active but less toxic than trans-retinoic acid (6). In 
order for these modified retinoids to be useful clinically, structural modifications must be 
made to increase hydrophilic properties of the molecule which will enhance transportation 
in the plasma thereby improving drug efficacy in terms of reaching tumor sites. This 
should allow smaller dosages of the retinoid since a higher percentage of the drug could be 
made available to the malignant tissue. Successful attempts in synthesizing the first 
heteroarotinoids came from both our lab as well as from Dawson and co-workers.18, 123 It 
was our conception to incorporate a heteroatom such as oxygen into the cyclohexyl ring 
and to include in the side chain an aryl group with a polar, para-substituent such as a 
CH20H, CHO, or a C02R group. Such modifications should increase the polarity of the 
molecule and greatly increase its ability to hydrogen bond to polar substances. It was 
observed that some of the active metabolites obtained from the metabolism of the retinoic 
acid (6) contained polar groups.66, 80 
We have successfully obtained a variety of heteroarotinoids which display activity 
comparable to that of all-trans-retinoic acid (6) in the hamster trachael organ culture 
assay .103 Reported herein are the synthesis of a series of heteroarotinoids 21 and 60a-601 
34 
35 
along with pharmacological activity of selected heteroarotinoids as 60a, 60b, 60c, and 
60d. In these heteroarotinoids, oxygen has been incorporated into the fused ring moiety. 
Synthesis of Heteroarotinoids 
Various synthesis involve 21, 60a-601 and 61-68 which are shown in Tables V and 
VI and Figures 6-10. Required intermediates are 61-68. The final step used to form the 
C(ll)-C(13) double bond in the heteroarotinoids 60a, 60b and 60g took advantage of a 
Wittig reaction by using the ylide 60 from 67 and the appropriate aldehyde such as 68-70. 





Reduction of ester 60a with UA1H4 gave the primary alcohol 60d in a modest yield of 
25%. Apparently there is a steric factor since the yield could not be improved even after 48 
h at reflux and in the presence of excess LiA1H4. Saponification of ester 60a gave acid 21 
(86.1 %). 
Using p-formylbenzonitrile (69) in a Wittig reaction (ylide 60) produced nitrile 60b 
again in modest yield (26%) as a pure (E)-isomer. Reduction of nitrile 60b with excess 
DIBAL-H in hexane gave aldehyde 60c (26% as a single (E)-isomer). Primary amine 60e 
(21 %) was obtained from nitrile 60b when the latter was reduced with UA1H4/THF. An 
unidentified by-product was noted in the TLC analysis. Addition of excess freshly 
prepared methylmagnesium iodide to nitrile 60b gave, after the normal workup, ketone 
60f (22%). The unusual aldehyde 70 and tlie anion of salt 67 gave ester 60g (19%) after 












I ~CN CH3 
60c 
I ~CHO CH3 
60d 
I ~CHzOH CH3 
37 




60f ~-CH3 CH3 I 
60g 
~ ~CHzOAc CH3 
60h 
I NcozcH3 CHzOH 
38 
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(2) 95% EtOH (2) Reflux, 8h 
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Since metabolites of these arotinoids may be oxidized derivatives, attention was 
focused upon the synthesis of such derivatives. Initial attempts to oxidize the methylene 
carbon [C(2)] in ester 60a with Ru02 • x H20 in CC14 in the presence of Nai04 at room 
temperature gave, after 48 h, unreacted ester 60a (- 20%) and 4-acetoxybenzoic acid (71, 
15%) rather than the target lactone 72. A few cyclic ethers have been reported to be 
converted to a corresponding lactone by this technique.102 Thus, bond cleavage resulted in 
60a to some degree at C(11)-C(13). Another effort to obtain lactone 72 involved the use 
of the Sharpless method.ll In CC14:H20:CH3CN (the solvent system and ratios used is 
critical here) with Ru04 prepared in situ (from Ru02 • x H20 and Nal04) both ester 60a 
(- 15%) was recovered along with aldehyde-ester 68 (- 12%). Again, cleavage of the 
double bond at C(ll)-C(13) occurred. Preparing Ru04 in situ from Ru02 • x H20 and 
K-metaperiodate and K2C03 (same solvent system as above) did not produce lactone 72 
from ester 60a but did yield ketone 65 and aldehyde-ester 68 in high yields. This 
interesting cleavage appears to be nearly quantitative via TLC analysis of the reaction 
mixture. The same results were observed with ZnCr20 7 • 3H2023 or pyridinium 
chlorochromate. 8 
It was discovered, however, that the methyl carbon [C(l2)] in ester 60a could be 
oxidized by Se02 in 95% ethanol to give, surprisingly, (E)-alcohol60k (15%) along with 
the expected Z-isomer 60h (2%). There is a peripherally related analogy in the literature 
where (E)-3-methyl-2 pentane was oxidized with Se02 to give isomeric mixture of the 
products.109 Purification required tedious and careful handling to obtain pure alcohol 60k. 
Oxidation of allylic carbons to produce allylic alcohols are known.l6 However, the 
isomerization of the double bond in the reaction 60a-60k is difficult to explain. Additional 
experimental work is needed to determine a possible mechanism for this isomerization. 
The stereochemical designation for 60k rests upon UV, and lH, and 13C NMR analysis. 
42 
Saponification of 60k gave the acid-alcohol 601 (56%). To the best of our knowledge, 
these are the only examples of heteroarotinoid systems with an oxidized group on the side 
chain. 
Several methods for the synthesis of the chroman ring system are available.9, 14, 123 
Phosphonium salt 67 was prepared by using a modified method from our laboratory.123 
All yields have been optimized and are in excess of those reported for 62-67. 3-Phenoxy 
propionic acid (61) was esterified using a Soxhlet-extractor, 3 A type molecular sieve and 
methanol at reflux for 46 h. The yield of ester 62 from this reaction was excellent (94% ). 
Addition of ester 62 in ether to freshly prepared solution of methylmagnesium iodide in 
ether afforded alcohol 63 (82.6% ). Ring closure of the alcohol 63 to ether 64 was carried 
out with AlC13 (anhydrous) in freshly distilled nitromethane. A normal workup, consisting 
of acidification, neutralization, and extraction, gave the final pure ether 64 (95.6% after 
distillation). 
4,4-Dimethylchroman 64 was acetylated by treatment with distilled acetyl chloride and 
anhydrous aluminium chloride in nitromethane. This reaction was stirred at room 
temperature for 6 h and after quenching in acid and extraction into ether, gave ketone 65 
(89.0% after distillation). 
Addition of the ketone 65 in dry ether to a suspension of LiAIH4 in dry ether under 
nitrogen gave, after quenching in acid and extraction into ether, alcohol 66 as a yellow 
solid. After repeated decolorization with charcoal, a snow white, solid alcohol66 (82.9%) 
was obtained. The triphenylphosphine hydrobromide (73) was prepared by using a 
known method 84 whereby HBr gas was passed through a solution of triphenylphosphine 
in ethyl acetate. Recrystallization of the final product from CH2Cl2/ethyl acetate gave a 
white crystalline solid 73 (80% ). The phosphonium salt 67 was prepared by treatment of 
methanolic solution of alcohol 66 with triphenylphosphine hydrobromide (73) at room 
temperature for 24 h. Concentration of the resulting solution repeated trituration with ether 
resulted in, the targeted phosphonium salt 67 in an excellent yield of 96. 9%. 
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Figure 7. Conversion of 60a, 60b, and 60h, to Yield 60k, 60h, 60f, 601, 
Respectively 
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Figure 10. Synthesis of Heteroarotinoids 60a, 60i, 60b, 60j, and 60g 
47 
A Wittig reaction involving the anion from phosphonium salt 67 was attempted with 
methyl 4-formylbenzoate (68) under a variety of different conditions (Table VII). The 
anion of the phosphonium salt 67 was prepared in ether (dry) at the room temperature by 
using 1.5 equivalents of n-BuLi. The resulting solution was cooled to -78·c, and the 
resulting anion was treated with a solution of aldehyde 68 in ether. Workup produced a 
yellow oil which was most easily purified by using a silica gel column with 80% 
hexane:ethyl acetate as the elution system. lH NMR spectral analysis of the resulting solid 
indicated the presence of the desired heteroarotinoid 60a and small amount of the 
corresponding isomer 60i in a ratio of 10:1. The (E)-isomer 60a was obtained in pure 
form ( 41 %; mp 90-9o.s·c) by recrystallization from 95% C2H50H. The mother liquor 
contained predominantly the pure (Z)-isomer 60i as white needles, mp 80-8o.s·c. 
Methyl4-formyl benzoate (68) used in the Wittig reaction was prepared by treating 4-
formyl benzoic acid (74-Aldrich) with methanol and a catalytic amount of sulfuric acid. 
Boiling the solution over 3 A molecular sieve for 48 h and gave, after a workup consisting 
of acidification to destroy any acetal of 68 formed during the reaction, neutralization and 
extraction, the fmal methyl4-formylbenzoate (68), in a yield of 58% after recrystallization. 
Reaction of ester 60a with a suspension of LiAIH4 in dry THF under nitrogen during 8 
h at reflux gave, after quenching in acid an extraction into ether a thick yellow oil. Pure 
alcohol60d was obtained after separating the yellow oil on chromatotron by using a 4 mm 
silica gel plate with 80% hexane:ethylacetate as an eluent. The solid obtained was 
recrystallized to give 60d (25%) with amp 79-80°C. 
The synthesis of a heteroarotinoid 60b paralleled that for formation of ester 60a. A 
Wittig reaction was applied involving the union of phosphonium salt 67 with 
4--cyanobenzaldehyde (69) with two different solvents and with three different ratios of 
n-BuLi to (67). The results are summarized in Table VIII. 
(E)-isomers 60b predominated in ether when a 1.5 ratio of n-BuLi to 67 was utilized. 
The final yield of the heteroarotinoid (E)-isomer 60b was, after recrystallization from 95% 
TABLE VII 
EFFECT OF SOL VENTS AND BASE ON WITTIG REACTION OF 67 -t 60 -t 
~ 60a and 60i 
Solvent n-BuLi Yield (%) Of 60a and 60i 
Anion Preparation Addition of Ester Number of E z 
Equivalents 
Ether (dry) Ether (dry) 1.0 35 1 
Ether (dry) Ether (dry) 1.5 41 2 
Ether (dry) THF (dry) 1.5 39 
Ether (dry) DMSO(dry) 1.5 4 
THF (dry) THF (dry) 1.2 28 
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TABLE VIII 
EFFECT OF SOL VENTS AND BASE ON WITTIG REACTION OF 67 ~ 60 ~ 
~. 60b and 60j 
Solvent n-BuLi Yield(%) Of 60b and 60j 
Anion Preparation Addition of Ester Number of E-Isomer Z-Isomer 
Equivalents 
Ether (dry) Ether (dry) 1.0 36 
Ether (dry) Ether (dry) 1.5 48 0.5 
Ether (dry) THF (dry) 1.2 10 
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50 
ethanol, 48.6%. The mother liquor contained predominantly the (Z)-isomer 60j in a very 
low yield (0.51% ). 
Reduction of the nitrile 60b was achieved in dry THF with the aid of LiAlH4 to give a 
yellow oil. Chromatography of the oil on a silica gel column using ethyl acetate:ethanol 
(1:1) as an eluting solvent gave a new oil. The final amine 60e was obtained, after several 
days of refrigeration, as a solid which upon crystallization, melted at 103-105°C. No (Z)-
isomer was observed in the crude mixture. 
Addition of nitrile 60b in ether to a solution of freshly prepared methylmagnesium 
iodide afforded, after workup, a yellow oil. The yellow oil was chromatographed using a 
silica gel column. Elution was effected with benzene. The final ketone 60f was obtained, 
after recrystallization, as a solid and melted at 88-89°C. 
Aldehyde 60c was prepared by treating a solution of nitrile 60b in ether with 
DIDAL-H in hexane. After workup, a viscous yellow oil was obtained which was 
chromatographed using a silica gel column with 80% hexane:ethyl acetate as a solvent 
system. After recrystallization (hot hexane), solid aldehyde 60c (26%) melted at 85-86°C. 
Heteroarotinoid 60g was formed from reaction of the Wittig reagent from 67 (in ether 
using n-butyllithium in hexane) at room temperature. The resulting anion was treated with 
a solution of 5-acetoxymethyl-2-furaldehyde (70) in dry THF. A yellow oil formed and 
was chromatographed on a silica gel column using 80% hexane:ethyl acetate. The 
heteroarotinoid ester 60g (19%) was obtained as a white crystalline solid (mp 80-81 °C) 
after recrystallization (hexane). No (Z)-isomer was detected in the mixture. 
The allylic oxidation of ester 60a to alcohol-ester 60k was carried out with ester 60a 
in 95% ethanol and Se02. The reaction mixture was heated at reflux for 24 h during which 
time elemental selenium formed as a black suspension. After workup, a yellow oil was 
obtained and was chromatographed using a silica gel column with 80% hexane:ethyl 
acetate. The lH NMR spectral data of the resulting oil indicated predominantly the 
presence of (E)-isomer 60k. A small amount(= 5%) of the corresponding (Z)-isomer 60h 
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was obtained as an oil and was estimated to have a purity of 86%. The (E)-isomer 60k 
was obtained in pure form by recrystallization (absolute ethanol) with cooling in 
refrigerator for several days and scratching to induce crystallization, mp 85-86·c. 
Saponification of ester 60h produced acid-alcohol 601 (56%) mp 198-199·c (absolute 
ethanol/pentane). 
Spectral Analysis of the Heteroarotinoids 
The lH NMR spectral analyses for the heteroarotinoids 21, and 60a-601 are given in 
the Experimental Section. The assignments for the 13C resonances shown in Tables IX-
XV were aided by observed splitting patterns from off-resonance spectra and from the 
comparison with the spectra of known heteroarotinoids such as 18, 19, and 75a-75d)8, 
64, 123 In the compounds 21, and 60a-60f, the assignments for the aromatic protons 
H(5), H(7), and H(8) of the chroman ring were made from analysis of the actual splitting 
pattern in the spectra. In heteroarotinoids 21, 60a-60f, H(5) was expected to give a 
doublet with J = 2-3 Hz and the actual value observed was J = 3 Hz. Likewise, H(7) gave 
the expected ortho and meta couplings and a doublet of doublets pattern with J = 3 Hz for 
the meta-coupled proton [H(5)] and J =9Hz for ortho-coupled proton [H(8)]. Moreover, 
H(8) was expected to give a doublet for 3J7, 8 in the range of J = 7-10Hz which was 
actually seen in 21, and 60a-60f with a value of 9 Hz. 
In 21, and 60a-60f, the vinylic proton [H(l3)] gave a singlet in the region of s 6.33-
6.80. In known (E)-arotinoids 18, 19, 21, and 75a-7Sd64, 123, the vinylic proton 
[H(13)] was a singlet at 6.82, 6.77, 6.77, 6.80, 6.82, 6.80 and 6.86, respectively. In the 
heteroarotinoids 21, and 60a-60f, the vinylic methyl group [H(l2)] gave a singlet in the 
region of s 2.2-2.3. In the known (E)-arotinoids 18, 19, 21, and 75a-75d, the 
corresponding signals at o 2.30, 2.37, 2.30, 2.27, 2.28, 2.27, and 2.28, respectively. A 
comparison of these data with that for 21, and 60a-60f indicated the latter should have the 





























2 63.1 63.1 
3 37.6 37.6 
4 30.7 30.7 
9 31.1 31.7 
10 31.1 31.7 
12 17.8 17.9 
5 124.6 124.6 
7 124.9 124.9 
8 116.6 116.8 
13 125.0 129.6 
15(19)a 129.1 129.0 
16(18)a 130.1 129.5 
Sa 153.5 153.4 
20 172.0 191.8 
Nonprotonated 126.8 129.7 
Aromatic and Vinylic 131.4 131.4 
Carbons 135.6 135.5 
139.9 140.4 
144.3 145.1 
*Chemical Shifts in ppm. 
aMay be interchanged. 
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TABLE X 
13C NMR DATA FOR THE HETEROAROTINOIDS 60d and 60e 
18 20 
12 12 HzNHz 
9 






13C NMR DATA FOR THE HETEROAROTJNOIDS 60f and 60g 






2 63.1 63.1 
3 37.6 37.6 
4 30.7 30.7 
9 31.0 31.1 
10 31.0 31.1 
12 17.8 18.2 
21 26.6 
5 124.5 124.4 
7 124.9 124.8 
8 116.8 116.8 
13 125.0 131.3 
15(19)a 128.3 114.2b 
16(18)a 129.2 109.5C 
8a 153.4 
18 58.3 
20 197.7 20.9 
19 170.7 
Nonprotonated 131.3 135.6 
Aromatic and Vinylic 134.7 136.9 
Carbons 135.6 147.7 
139.7 153.3 
144.6 154.6 
*Chemical Shifts in ppm. 
aMay be interchanged. 
bQnly for C(15). 
COnly for C(16). 
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TABLEXTI 
lH AND 13C NMR DATA FOR THE HETEROAROTINOIDS 60a and 60i 
60a 
£-Isomer 



















*Chemical Shifts are in ppm. 

















































lH AND 13C NMR DATA FOR THE HETEROAROTINOIDS 60b and 60j 
60b 
E-Isomer 


















*Chemical Shifts are in ppm. 






















































doublet for each proton with J = 3.2-3.8 for the ortho-couplings88 while the actual 
observed value was J = 3 Hz. 
A HETCOR 2-D NMR experiment can be used to correlate the lH NMR chemical shift 
of a particular set of protons with 13C NMR chemical shift of the corresponding carbon. 43 
In order to utilize the information contained in a 2-D or contour plot, either the lH or 13C 
NMR assignments must be known unequivocally. A comparison of the contour plot from 
the HETCOR 2-D NMR experiment, the 13C NMR spectrum in the region between 25 and 
65 ppm, and 1 H NMR spectrum between approximately s 1.0 and 4.5 allowed 
confirmation of assignments for H(2) and H(3) in 60i and 60j. More detail concerning the 
use of HETCOR 2-D NMR experiment is available in Chapter II. The 13C NMR 
assignments for the protonated aromatic and olefmic carbons of 60i and 60j (Table XII 
and XIII) were made by using HETCOR 2-D NMR experiments over the aromatic region. 
The results of these experiments are shown in spectra as Figures 11-16. 
A comparison of an (E)-isomer with a (Z)-isomer of a modified retinoid with respect to 
the corresponding lH NMR and 13C NMR chemical shifts could not be found in the 
literature. It is clear from data in Tables XII and XIII that in spectra of the (E)-isomers 
nearly all of the lH NMR shifts are downfield as compared to those of the (Z)-isomers. 
The 13C NMR chemical shifts are comparable in both of the (E) and (Z)-isomers 60a and 
60b except the chemical shift for C(l2) which is upfield (17.8 ppm) in the (E)-isomer from 
that in the (Z)-isomer (26.8 ppm). 
The (E)-geometry at the double bonds in 21, and 60a-60h was supported by making 
a comparison of the lH NMR spectra with that of the known (E)-isomers 18, 19, and 
75a-75d. In (Z)-isomers, 60i and 60j, vinylic protons H(13) signals were shifted 
upfield by approximately 0.33 ppm from that of the corresponding (E)-isomers 60a and 
60b. Similar shifts have been reported for the vinylic protons of cis-stilbene (76) 























Figure 11. 13C NMR and lH NMR Spectra of 60i in the Aliphatic Region. 
60 
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In related (Z)-arotinoids 77a and 77b the vinylic protons (CH = C-CH3) gave singlets at o 
6.46, and 6.45, respectively, while (Z)-heteroarotinoids 60i and 60j gave singlets at o 
6.43 and 6.42, respectively. In the (Z)-arotinoids 77a and 77b, the vinylic methyl groups 
[CH = CH-CH.3] gave singlet, at o 2.23 and 2.20, respectively, while in (Z)-
heteroarotinoids 60i and 60j, the singlets occurred at o 2.21 and 2.22, respectively. 
Although none of the structures have been subjected to x-ray analysis, a comparison of 
these NMR data strongly suggests that heteroarotinoids 60i and 60j have the Z-
configuration. Space filling models (Courtauld) imply that H(12) and H(l3) in the (Z)-
67 
isomers may be positioned to a small degree within the shielding cones of the respective 
aryl rings. 
A study was made of the ultraviolet (UV) spectra of members of 60. The extinction 
coefficients (E) and the UV absorption maxima ("max) were greater in the (E)-isomer than in 
the (Z)-isomer (Table XV), which supported the stereochemical assignments for 60a, 
60h, 60i, and 60k. As expected the cis-isomers 60i and 60k had smaller A max values 
since misalignment of p-orbitals in the conjugated alkene system is suspected due to 
molecular crowding which results in disrupted conjugation. The oxidation product 
(alcohol-ester 60k) obtained from the Se02 oxidation of 60a surprisingly showed the 
presence of (E)-isomer 60k with the aryl groups syn to each other. This syn arrangement 
for the aryl groups in60k was assigned after comparison of the lH NMR chemical shifts 
and of the UV maxima with those of model compounds 77 a 64 and 77b (reported as a 
crude oi1)18. For example, the UV spectrum of 60k was comparable with that for cis-
stilbene (76b) as well as with the arotinoids 77a and 77b (Table XV). In 77a, the A max 
was 297 run with£= 1.4 x 104, while in heteroarotinoid 77b the values were 306 nm and 
1.2 x 104. Heteroarotinoid 60i, had A max at 310 nm with£= 1.61 x 104 while (E) isomer 
60k had values of A max 302 nm and E = 1.5 x 104. In contrast, in isomers 60a, 60h, 
and 7 Sa larger A max values and larger E values were observed suggesting better 
conjugation as expected with the larger aryl rings in an anti arrangement around the double 
bond. 
Pharmacological Activity of the Heteroarotinoids 
Inhibition ofQDC Induction. The pharmacological activity ofheteroarotinoids 60a, 60b, 
60c, and 60d was evaluated at the University of Wisconsin by Dr. A. K. Verma using 
ornithine decarboxylase (ODC) assay developed by Boutwell and Verma121 as discussed in 
Chapter I. When mouse skin is treated with 12-0-tetradecanoylphorbal-13-acetate (TPA), 
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TABLE XVI 
DATA FROM THE ODC ASSAY WI1H THE HETEROAROTINOIDS 
Heteroarotinoid Test System Retinoid Dose, ODC Percent of Inhibition as 
nmol 
Acetone 0.0 
Acetone + TP A** 0.0 
3+ TPA** 17 
60a 60a + TPA** 34 
60b 60b + TPA** 34 
Acetone 0.0 
Acetone+ TPA** 0.0 
6 + TPA** 34 
60c 60c + TPA** 
60d 60d + TPA** 
*n mol C02/ 60 min/mg protein. 
**Refer Figure 2 in the Chapter I. 
34 
34 
Activity* Compared to Control+ 
0.0 ± 0.0 
1.67 ± 0.14 Control 
0.14± 0.04 92 
0.95 ± 0.06 43 
1.77 ± 0.32 
0.0 ± 0.0 
5.3 ± 0.7 Control 
1.0 ± 0.1 81 
3.5 ± 0.2 34 
1.7 ± 0.1 68 
+The percentage of Inhibition as compared to control was calculated as shown: 
(ODC with Acetone+ TPA)- (ODC with retinoid) x 100 
(ODC with Acetone + TP A) 
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is associated with an increase in the proliferative activity of the tissue. Retinoids prevent 
this induction, and the relative effectiveness of a retinoid to inhibit the TP A-induced 
production of ODC can be used as a basis for measuring biological activity of the test 
compound. 
The preliminary assays of 60a, 60b, 60c, and 60d have been completed and 
summarized in Table (XVI). A comparison of the % inhibition of the formation of tumor, 
by 60a, 60b, 60c, and 60d (along with the % inhibition of the formation of tumors in 
systems with the standards 13-cis-retinoic acid (3) or trans-retinoic acid (6), indicate that 
heteroarotinoid 60d inhibited tumor formation by 68% at the 34-nmol dose and had the 
strongest activity of any heterocycle tested. The heteroarotinoid 60a prevented tumor 
formation by 43% at 34-nmol dose and heteroarotinoid 60c showed 34% inhibition of 
cancerous cell growth. Both 60a and 60c exhibited much smaller activity than alcohol 
60d. The heteroarotinoid 60b was essentially inactive at the 34 nmol dose and induced 
greater ODC activity than the control. 
Recently, it was shown by Breitman and co-workers that retinoids, including 
arotinoids, can induce terminal differentiation of several types of neoplastic cells and that 
the measurement of such a response can be used for rapid and quantitative assays of 
activity.lll The Ill..-60 cell line was used for this purpose and cell differentiation was 
induced by arotinoid such as heteroarotinoid 60a. These mature cells, unlike the 
uninduced Ill..-60 cells, produced superoxide anion when stimulated with an appropriate 
agent such as TPA.lll The ability of individual cells to produce superoxide was measured 
by incubating cells with water soluble yellow dye, nitroblue tetrazolium chloride (NBT) 
Figure 17. NBT was reduced to a water-insoluble, blue-black formazan by superoxide. 
The formazan precipitate was associated with those cells that produced superoxide. Thus, 
the percentage of cells in a population that produces superoxide (NET-positive cells) was 
enumerated under a light microscope. The concentration of retinoid effective in achieving 




Figure 17. Nitro Blue Tetrazolium Chloride (NBT) 
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concentration tested, as compared to the ED so of 41 nm for trans-retinoic acid (standard). 
At a concentration of 3 J,LM, heteroarotinoid 60a induced approximately 15% of the cells, 
as compared to the control. 
These screening results are still preliminary. To get ED 50 values, these assays should 
be run at a variety of concentrations of the heteroarotinoids. Previous results with only a 
few related systems obtained from our laboratory are promising. 123 One objective of our 
work was to obtain heteroarotinoids which had increased hydrophilicity and lower 
lipophilicity with, hopefully, concomitant lower toxicity. The incorporation of the 
heteroatom, such as oxygen, into the basic arotinoid structure and with a para substituent 
on the aryl group resulted in good activity in terms of the ornithine decarboxylase assay for 
60d.121 This appears to meet the first objective. Toxicity studies which are in progress 
will determine the overall effectiveness of heteroarotinoids 60a, 60d, 60c, and 60d. It 
also appears that the presence of the rigid syn arrangement of carbons at the 4-, 15(19)-, 
16(18)- and 17-positions in the aryl ring do not alter significantly the activity normally 
73 
associated with long polyene chain, for example, as in 13-cis-retinoic acid (3). Biological 
activity studies of the heteroarotinoids 60g, 60e, 60f, 60i, 60k, and 601 are in progress. 
Suggestions for Future Work 
Toxicity studies done by Dawson and co-workers with Femal Swiss mice suggested 
that acid 19 and acid 21 are less toxic than trans-retinoic acid (6) and therefore have 
potential value in the treatment of proliferative skin diseases. IS Toxicity studies of the 
heteroarotinoids 21, and 60a-601 must be performed to determine what effect, if any, the 
para-substituent on phenyl ring has on activity along with the incorporation of oxygen 
heteroatom in the ring. Compare relative biological activity of 2 isomers such as the 
(E)-isomer and (Z)-isomer for the heteroarotinoids 60a, 60i, 60b, 60j, 60h, and 60k, 
respectively. At this point the reason is not evident why the E-configuration in the 
heteroarotinoid 60a is not preserved to give the (Z)-isomer 60h rather than the isolated 
(E)-isomer 60k in the Se02 oxidation reaction. Additional heteroarotinoids should be 
examined under the same reaction conditions to confirm that syn arrangement of the phenyl 
rings results as a general rule. X-Ray diffraction analysis of the heteroarotinoid 60i or 60j 
should be useful to determine space orientation of groups in these supposedly strained 
systems. 
Other modifications which could prove useful include: (1) cyclopropination and 
epoxidation of the vinylic double bond to afford acids 78a and 78b; (2) oxidation of one 
methyl group of the gem-dimethyl function since such a system has been reported as a 
metabolite from the retinoic acid to give heteroarotinoids 79a and 79b; (3) oxidation of all 
methyl groups to yield heteroarotinoids 79c and 79d; (4) lactone formation by oxidizing 
C(2) to give 72, for example. 
Since attempts to make the lactone 72 from ester 60a in one single step were 
unsuccessful to date an alternative route to the lactone 72 is postulated below. Phenol and 
3-methylcrotonyl chloride are the suggested starting materials which can be obtained from 
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Aldrich Chemical Company, USA. Conversion of phenol (80a) to lactone SOc is reported 
in the literature.l5 Lactone 80c18 can be protected by a specific reagent such as bis 
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Reactions were carried out under a nitrogen atmosphere when necessary. All reactions 
were stirred using a magnetic stirrer unless otherwise specified. During work-up, solvents 
were removed using a rotary evaporator unless otherwise stated. NMR spectral data were 
obtained using either a Varian XL-100 :mv1R spectrometer equipped with a Nicolet TT-100 
PFI' accessory or a Varian XL-300 NMR spectrometer. The lH spectra were recorded at 
300 MHz while 13C spectra were recorded at 25.14 or 75.42 MHz. All NMR data were 
reported in ppm or o values downfield from 1MS using either 1MS, CDC13 or DMSO-~ 
as an internal reference. IR spectral data were obtained using a Perkin-Elmer 681 IR 
spectrophotometer. UV spectra were taken on the Perkin-Elmer Lamda Array 3840 UV-
VIS Spectrophotometer with 7300 Professional Computer PR 210 Printer. Melting points 
were determined using a Thomas Hoover melting point apparatus and were uncorrected. 
All solvents were distilled prior to use except for reagent grade, anhydrous ether which was 
dried over sodium. Starting compounds 21,123 62-67,123 and 68 58 were prepared by 
modifications of reported procedures. 
Methyl3-Phenoxypropionate (62) 
A solution of 3-phenoxypropionic acid (61, 48 g, 289.07 mmol) and concentrated 
H2S04 (0.90 mL) in methanol (700 mL) was heated at reflux through 3 A molecular sieve 
for 46 h in a 1 L flask equipped with a Soxhlet extractor and a condenser. The solution was 
allowed to cool to room temperature and then was concentrated to a volume of 150 mL, 
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77 
diluted with water (150 mL) and extracted with ether (4 x 50 mL). The combined organic 
layers were washed with 100 mL of 5% NaHC03 solution, 100 mL of water and 100 mL 
of saturated NaCl solution. After the solution was dried over MgS04 (30 min.), the 
solvent was removed (vacuum). Vacuum distillation gave 48.39 g (94%) of 62 as a 
colorless liquid: bp 69-72oC/0.03 mm (lit123 85-87°C/0.1 mm); IR (neat) 1740-1750 cm-1 
(C=O); 1H NMR (DCCI3) s 2.80 (t, 2 H, CHzC02CH3), 3.66 (s, 3 H, OCHJ), 4.23 (m, 2 
H, OCHz), 6.98-7.16 (m, 5 H, Ar-H); 13C NMR (DCCI3) ppm 34.4 (H~COv. 51.7 
(OC.H3), 63.3 (OC.Fiv. Ar-.C. (114.5, 120.9, 129.3, 158.3), 171.1 (C=O); mass spectral 
data for C10H1203: rnle (M+) 180.07864; found 180.0789. 
2-Methyl-4-phenox.y-2-butanol (63) 
To a freshly prepared solution [15.51 g (665.04 gat) of magnesium, 41.6 mL (665.0 
mmol) of methyl iodide] of methylmagnesium iodide in dry ether (132 mL) was added a 
solution of methyl 3-phenoxypropionate (62, 44.6 g, 214.5 nimol) in dry ether (145 mL) 
in a 1-L, three-necked, round-bottom flask equipped with dry ice condenser, addition 
funnel and mechanical stirrer under N2. The mixture was heated at reflux for 24 h with 
power stirring, allowed to cool to room temperature, and quenched with ice and saturated 
aqueous NH4Cl. The two layers were separated and the aqueous layer was extracted 
(ether, 4 x 120 mL). The combined organic solution was washed with H 20 (2 x 100 mL) 
and saturated NaCl solution (100 mL). After the solution was dried (MgS04, 8 h), the 
solvent was removed (vacuum). Vacuum distillation gave 36.8 g (82.6%) of 63 as a 
colorless liquid: bp 84-85°C 0.05 mm (lit123 81-84°C/0.07 mm); IR (neat) 3140-3620 
cm-1 (OH); lH NMR (DCCI 3) s 1.27 [s, 6 H, (CH.l)iJ, 1.98 [t, 2 H, C Hz], 2.9 [s, 1 H, 
OH], 4.14 [t, 2 H, OCHz], 6.82-6.96 [m, 3 H, Ar-H], 7.16-7.34 [m, 2H, Ar-H]; 13C 
NMR (DCCl3) ppm 29.5 [,C,H3], 41.6 [Of2-C], 64.8 [0C.Hv, 70.4 [ (CH3h,C.l, Ar-.C. 





A solution of 2-methyl-4-phenoxy 2-butanol (63, 41.10 g, 228.33 romol) in freshly 
distilled nitromethane (270 mL) was added dropwise under N2 to a stirred suspension of 
anhydrous AlC13 (41.43 g, 308.1 romol) in freshly distilled nitromethane (165 mL) in a 1-
L three-necked, round-bottom flask, equipped with a condenser. After stirring at room 
temperature for an additional 24 h, a solution of 6 M HCl (425 mL) was added slowly. 
The resulting mixture was stirred for 10 min and diluted with ether (200 mL). The layers 
were separated, and the organic layer was washed with H20 (200 mL), saturated NaHC03 
(4 x 150 mL), H20 (150 mL), and saturated solution ofNaCl (150 mL). After the solution 
was dried (MgS04, 30 min), the solvent was removed (vacuum). Vacuum distillation of 
resulting dark brown oil gave 27.96 g (75.6%) of 64 as a colorless liquid: bp 43-44oC/0.2 
rom (1it123 74-80°C/0.7 rom); lHNMR (DCC13) o 1.27 [s, 6 H, (CHJ)C], 1.83 [m, 2 H, 
CHiJ, 4.09 [m, 2 H, OCH2.l, 6.88-7.24 [m, 4 H, Ar-H]; 13C NMR (DCCl3) ppm 30.5 
[C_(CH3)2], 31.1 [(OI3)2C], 37.7 [C_H2), 63.0 [OC,H2], Ar-C, [116.9, 120.4, 126.9, 
127 .0, 131.6, 153.6]. 
4.4-Dimethyl-6-chromanyl Methyl Ketone or 1-(3.4-Dihydro-
4.4-dimethyl-2H -1-benzop,yran-6-yl)ethanone (65) 
Anhydrous A1Cl3 (2.99 g, 22.51 romol) was added in small portions to 4,4-dimethyl-
chroman (64, 3.45 g, 21.30 romol) and acetyl chloride (1.51 mL, 21.30 mmol) in 
CH3N02 (30 mL) under N2 in a 100-mL, three-necked, round-bottom flask equipped with 
condenser. After stirring at room temperature for 6 h, 6 M HCl (30 mL) was added 
slowly, and the resulting mixture was stirred for 10 min. The mixture was diluted with 
ether (70 mL) and layers were separated. The organic layer was washed with H20 (50 
mL), saturated aqueous NaHC03 (4 x 40 mL), H 20 (50 mL), and a saturated solution of 
NaCl (50 mL). After the solution was dried (MgS04, 30 min), the solvent was removed to 
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leave a dark, reddish brown oil. Vacuum distillation gave 3.09 g (89.03%) of 65 as a pale 
yellow liquid: bp 94-95.C/0.1 mm [1it123 108-112.C/0.01 mm]; IR (neat) 1675-1685 cm·l 
(C=O); lH m.1R (DCC13) a 1.38 [s, 6 H, (CH1hC], 1.84 [m, 2 H, CH2], 2.52 [s, 3 H, 
CH1C], 4.26 [m, 2 H, CHzO], 6.82 [d, 1 H, H(8)], 7.71 [dd, 1 H, H(7)], 7.99 [d, 1 H, 
H(5)]; 13C NMR (DCC13) ppm 26.1 ~H3], 30.5 [{;.(CH3hl, 30.6 [CC.H3)2C], 37.0 
[c.H21, 63.3 [c_H20], 116.7 [C(8)], 127.5 [C(5)], 127.9 [C(7)], 130.0, 131.6 [C(4a), 
C(6)], 157.8 [C(8a)], 196.4 [C=O]; mass spectral data for C13H1s02: m/e (M+) 
204.11500; found 204.1155. 
a. 4.4-Trimethylcbroman-6-rnethanol or 3.4-Dihydro-4.4-
trimethyl-2H -1-benzmzyrau-6-rnethanol ( 66) 
A solution of the previous ketone (65, 180 g, 88.1 mmol) in anhydrous ether (80 rn.L) 
was added dropwise under N2 to a stirred suspension ofLiAlH4 (5.01 g, 132.27 mmol) in 
dry ether (315 mL) in a 500-mL, three-necked flask equipped with condenser. The mixture 
was heated at reflux for 24 h. After cooling to room temperature, ethyl acetate (85 rn.L) 
was added dropwise to destroy the excess of LiAIH4• A solution of 5% HCl (255 rn.L) 
was then added, and the resulting mixture was stirred for 5 min. The layers were 
separated, and aqueous layer was washed with ether (3 x 150 mL). The combined organic 
layers were washed with 5% aqueous NazC03 (2 x 100 rn.L), water (150 mL), and 
saturated NaCl solution (150 mL). After the solution was dried (MgS04, 30 min), the 
solvent was removed leaving a yellow oil which solidifed after scratching. The yellow 
solid was dissolved in a minimum amount of hot hexane to which was added decolorizing 
carbon NORITE (0.4 g). This solution was boiled for 2 min. and filtered through celite. 
The solvent was removed on rotary evaporator which left behind a colorless oil. After 
overnight refrigeration, a white solid was obtained. Recrystallization (hexane) gave 15.25 
g (82.9%) of66 as a white solid: mp 71-72·c (1it123 70-71.C); IR (KBr) 3140-3640 cm·l 
(OH); 1H m.1R (DCC13) a 1.32 [s, 6 H, (CH~2C], 1.50 [d, 3 H, CH:3.], 1.31 [s, 1 H, 
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OHl, 4.20 [m, 2 H, H(2)], 4.84 [q, 1 H, CHOH], 6.76 [d, 1 H, H(8)], 7.07 [dd, 1 H, 
H(7)], 7.28 [d, 1 H, H(5)], 13C NMR (DCC13) ppm 24.9 IJ:.H3], 30.6 [C(4)], 31.0 
[(!:,H3hC], 37.6 [C(3)], 62.9 [C(2)], 70.2 [C(9)], 116.8 [C(8)], 123.9, 124.2 [C(5), 
C(7)], 131.1, 137.6 [C(4a), C(6)]. 152.9 [C(8a)]. 
fl-( 4.4-Dimetbyl-6-chromanyDetbylltriphenylphosphonium 
Bromide or U-(3.4-Dihyc1ro-4.4-dimethyl-2H-1-benzo-
pyran-6-yl)ethylltriphenylphosphonium Bromide (67) 
A solution of the alcohol 66 (0. 70 g, 0.34 mmol) and triphenylphosphonium 
hydrobromide84 (1.2 g, 3.5 mmol) in methanol (30 mL) was stirred under N2 at room 
temperature for 24 h in a 50-mL, round-bottom flask. The solvent was removed (vacuum), 
and the resulting oil was triturated repeatedly with dry ether until it solidified. The resulting 
white solid was suspended and stirred in dry ether (30 mL) at room temperature under N 2 
for 4 h, filtered, and dried (llOoC/- 2 mm) to give 1.75 g (96.9%) of 67 as a white 
powder: mp 152-156oC (dec) [lit123 149-155°C]; lH NMR (DCC13) a 1.08 [s, 3 H, CH3], 
1.14 [s, 3 H, CH.3.], 1.76 [m, 2 H, H(3)], 1.83 [d, 3 H, CHCH1], 4.16 [m, 2 H, H(2)], 
6.3 [m, 1 H, CHP+Ph3, Br], 6.57 [d, 1 H, H(8)], 6.67 [d, 1 H, H(7)], 7.74 [brs, 1 H, 
H(5)], 7.63-7.84 [m, 15 H, P+(C6li,s.)J]. The salt was used without further purification. 
Methyl4-Fonnylbenzoate (68) \ 
A 500-mL, three-necked, round-bottom flask was equipped with a teflon-coated 
stirring bar, Soxhlet extractor and condensor with a drying tube at the top. The flask was 
charged with 10.0 g (66.6 mmol) of 4-formyl benzoic acid (71), about 320 mL of absolute 
CH30H, and 0.1 m1 of concentrated H2S04. The Soxhlet extractor was filled with 3 A 
molecular sieve. After the solution was boiled for 48 h, it was allowed to cool to room 
temperature and then was concentrated to a volume of about 50 mL; dilution with an equal 
amount of water followed and the new solution was extracted (ether 4 x 70 mL). The 
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combined organic layers were washed with saturated NaHC03 solution (5 x 50 rnL), 0.1 N 
HCl (10 x 40 rnL), H20 (2 x 50 mL), and saturated NaCl solution (2 x 50 rnL). The 
resulting organic solution was dried (MgS04, 2 h) and filtered and concentrated in vacuo. 
The white solid obtained was recrystallized (hexane) to give 6.3 g (58%) of ester 68: mp 
59.5-60·c (lit58 59-60.C); IR (KBr) 1680-1740 cm-1 (C=O); lH NMR (DCC13) a 4.00 (s, 
3 H, OCH:J)• 7.80-8.32 (m, 4 H, Ar-H), 10.10 (s 1 H, CliO); 13C NMR (DCC13) ppm 
52.6 [0C.H3], Ar-.C. [129.6, 130.4, 135.2, 139.2], 166.0 [.C.02CH3], 191.7 [CHO]; mass 
spectral data for C9Hg03: m/e (M+): 164.0473. Found: 164.0473. 
CEJ-4-f2-C3.4-Dihydro-4.4-dimethyl-2H-1-benzo.psrau-
6-yD-1-prQpenyllbenzoic Acid (21) 
The ester 60a (1.20 g, 3.58 mmol) was heated at reflux under N 2 for 5 h in a solution 
of NaOH (0.625 g, 15.69 mmol) in 95% ethanol (14 mL) and H20 (38 rnL) in a 50-rnL, 
three-necked, round-bottom flask equipped with a condenser. After cooling slowly to RT, 
the solution was acidified (litmus) with cone. HCl (pH= 2.0). The resulting white solid 
was filtered, washed with water, and air dried. Recrystallization (95% ethanol) gave 1.02 
g (86.14%) of acid 21 as a white crystalline solid: mp 180-180.5·c (lit123 183-183.5.C) 
IR (KBr) 2390-3320 (OH, CH), 1670-1695 cm-1 (C=O); lH NMR (DCCl3) o 1.40 [s, 6 
H, H(9), H(lO)], 1.88 [m, 2 H, H(3)], 2.3 [s, 3 H, H(12)], 4.25 [m, 2 H, H(2)], 6.80 [s, 
1 H, H(l3)], 6.84 [d, J = 9 Hz, 1 H, H(8)], 7.3 [dd, J = 9 Hz, J = 3 Hz, 1 H, H(7)], 
7.46 [d, J = 3Hz, 1 H, H(5)], 7.5 [d, J =9Hz, 2 H, H(15), H(19)], 8.14 [d, J = 9Hz, 2 
H, H(16), H(18)]; 13C NMR (DCCl3) ppm 17.81 [C(12)], 30.72 [C(4)], 31.08 [C(9), 
C(lO)], 37.63 [C(3)], 63.14 [C(2)], 116.85 [C(8)], 124.56 [C(5)], 124.93 [C(7)], 125.04 
[C(13)], 129.12 [C(15, C(19)], 130.12 [C(16), C(l8)], 153.46 [C(8a)], 172.03 [C(20)], 
nonprotonated and vinylic carbons [126.79, 131.36, 135.63, 139.91, 144.33]; mass 




A solution of n-butyllithium in hexane (1.39 M, 9.98 mL, 13.80 mmol) was added 
dropwise under N2 to a stirred suspension of phosphonium salt 67 (4.89 g, 9.20 mmol) in 
dry ether (90 mL) in a 250-mL, round-bottom flask. The resulting dark reddish brown 
mixture was cooled to -78°C, and a solution ofmethy14-formylbenzoate (68, 1.51 g, 9.2 
mmol) was added over a period of 3 min. The solution was stirred for a few min at -78oC 
and then at room temperature for 48 h. The mixture changed from reddish-brown to an off 
white color. After 48 h, the reaction mixture was filtered. The resulting solid was washed 
with 250 mL of ether (anhydrous); the filtrate was concentrated to a yellow oil. This 
yellow oil was refrigerated for 8 h and became a yellow solid. This yellow solid was 
passed through 30 g of silica gel [column, (8 x 200 mm)]. The product was eluted with 
300 mL of hexane:ethy 1 acetate ( 4: 1 ). Concentration of the eluent gave a viscous oil from 
which a solid was obtained at room temperature. The white solid was dissolved in a 
minimum amount of boiling 95% ethanol and filtered hot. After the filtrate was 
concentrated, cooling this solution to room temperature gave 1.29 g of white crystals of 
60a [(E)-isomer)] (40.3%): mp 90-90.5°C; IR (KBr) 1710-1725 cm-1 (C=O); lH NMR 
(DCC13) 5 1.4 [s, 6 H, H(9), H(lO)], 1.9 [m, 2 H, H(3)], 2.3 [s, 3 H, H(12)], 3.9 [s, 3 
H, H(21)], 4.2 [m, 2 H, H(2)], 6.80 [s, 1 H, H(13)], 6.84 [d, J = 9 Hz, 1 H, H(8)], 7.3 
[dd, J =9Hz, J =3Hz, 1 H, H(7)], 7.4 [d, J =3Hz, 1 H, H(5)], 7.5 [d, J =9Hz, 2 H, 
H(15), H(19)], 8.6 [d, J = 9 Hz, 2 H, H(16), H(18)]; 13C NMR (DCCl3) ppm 17.8 
[C(l2)], 30.7 [C(4)], 31.1 [C(9), C(lO)], 37.6 [C(3)], 52.1 [C(21)], 63.1 [C(2)], 116.8 
[C(8)], 124.5 [C(5)], 124.9 [C(7)], 125.9 [C(13)], 129.0 [C(l5), C(19)], 129.5 [C(16), 
C(l8)], 153.4 [C(8a)], 167.0 [C(20], non-protonated and vinylic carbons (127.6, 131.3, 
135.7, 139.5, 143.4); UV (EtOH) A-max 237 nm (e 1.5 x 104), 318 (2.5 x 104); mass 
spectral data for C22H2403: rn/e (M+) 336.1725; found 336.1728. Anal for CzzH2403: 
C, 78.59; H, 7.18. Found C, 78.39; H, 7.10. The mother liquor from the crystallization 
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of the (E)-isomer 60a contained predominantly the (Z)-isomer 60i (50 mg, 1.6%) as a 
white needles: mp 80-8o.s·c; lH NMR (DCC13) o 1.12 [s, 6 H, H(9), H(10)], 1.78 [m, 2 
H, H(3)], 2.20 [s, 3 H, H(12)], 3.86 [s, 3 H, H(21)], 4.17 [m, 2 H, H(2)], 6.43 [s, 1 H, 
H(13)], 6.73 [d, J =9Hz, H(8)], 6.95 [dd, J =9Hz, J = 3Hz, 1 H, H(7)], 7.03 [d, J = 
3Hz, 1 H, H(5)], 7.51 [d, J =9Hz, 2 H, H(15), H(19)], 7.78 [d, J =9Hz, 2 H, H(16), 
H(18)]; 13C NMR (DCC13) ppm 26.79 [C(12)], 30.42 [C(4)], 30.78 [C(9), C(lO)], 37.48 
[C(3)], 51.91 [C(21)], 63.08 [C(2)], 116.9 [C(8)], 125.0 [C(13)], 126.5 [C(7)], 126.5 
[C(5)], 128.8 [C(15), C(19)], 129.1 [C(16), C(18)], 143.1 [C(8a)], 167.0 [C(20)], 
nonprotonated and vinylic carbons (127.5, 128.8, 128.97, 132.9, 141.4); UV (EtOH) 
"max 245 nm (e 2.2 X 104), 310 (1.6 X 104); mass spectral data for C22H2403: mle (M+) 
336.17254; found 336.1729. Anal for C22H2403: C, 78.59; H, 7.18. Found C, 78.24; 
H, 7.38. 
(E.)-4-f2-Methyl-2-( 4.4-dimethyl-6-chromanyl)-1-propenyl]-
benzonitrile ( 60b) 
A solution of n-butyllithium in hexane (1.39 M, 14.1 mmol, 10.15 mL) was added 
dropwise under N2 to a stirred suspension of phosphonium salt 67. (5.00 g, 9.40 mmol) 
in dry ether (100 mL) in a 250-mL, three-necked flask. The resulting dark, reddish-brown 
mixture was cooled to -78·c and to this was added a solution of 1.56 g (9.4 mmol) 4-
cyanobenzaldehyde (69) in 50 mL of anhydrous ether over a period of 1 min. The solution 
was stirred for 5 min at -78·c and then at room temperature for 5 h. A new reaction 
mixture was filtered and the solid material was washed with anhydrous ether (30 rnL). The 
ethereal filtrate was evaporated to give a yellow oil which was refrigerated overnight to 
yield a yellow solid. The yellow solid was dissolved in a minimum amount of boiling 95% 
ethanol from which fine pale yellow crystals of nitrile 60b were deposited [1.43 g, 
48.6%]: mp 134-134.s·c; IR (KBr) 2220-2240 cm-1 (C=N); lH NMR (DCC13) o 1.80 [s, 
6 H, H(9), H(10)], 2.21 [s, 3 H, H(12)], 2.30 [m, 2 H, H(3)], 4.22 [m, 2 H, H(2)], 6.33 
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[s, 1 H, H(13)], 6.80 [d, J = 9Hz, 1 H, H(8)], 7.21 [dd, J =9Hz, J =3Hz, 1 H, H(7)], 
7.44 [d, J = 3Hz, 1 H, H(5)], 7.50 [d, J = 9Hz, 2 H, H(15), H(19)], 7.90 [d, J =9Hz, 
2 H, H(16), H(18)]; 13C NMR (DCCI3) ppm 17.8 [C(12)], 30.7 [C(4)], 31.6 [C(9), 
C(lO)], 35.6 [C(3)], 63.2 [C(2)], 116.9 [C(13)], 119.2 [C(20)], 124.3 [C(7)], 124.6 
[C(5)], 124.9 [C(8)], 129.7 [C(16), C(18)], 131.9 [C(15), C(19)], 153.6 [C(8a)], Non-
protonated and vinylic carbons [109.4, 131.6, 135.3, 140.6]; mass spectral data for 
C21H21NO: m/e (M+) 303.1623; Found 303.1627. Anal for C21H21NO: C, 83.13; H, 
6.97; N, 4.17. Found: C, 83.31 H, 6.72; N, 4.23. The mother liquor from the 
crystallization of the (E)-isomer 72 contained predominantly the (Z)-isomer 60j (15 mg, 
0.51 %) as a white solid: mp 89-90"C; lH N:MR (DCC13) a 1.14 [s, 6 H, H(9), H(10)], 
1.80 [m, 2 H, H(3)], 2.22 [s, 3 H, H(12)], 4.20 [m, 2 H, H(2)], 6.74 [s, 1 H, H(13)], 
6.78 [d, J = 9Hz, 1 H, H(8)]~ 6.96 [dd, 1 H, H(7)], 6.97 [d, 1 H, H(5)], 7.08 [d, J = 9 
Hz, 2 H, H(15), H(19)], 7.20 [d, J =9Hz, 2 H, H(16), H(l8)]; 13C NMR (DCC13) ppm 
26.74 [C(l2)], 30.41 [C(4)], 30.75 [C(9), C(lO)], 37.40 [C(3)], 63.10 [C(2)], 117.11 
[C(13)], 119.25 [C(20)], 124.27 [C(7)], 126.43 [C(5)], 127.63 [C(8)], 129.45 [C(16), 
C(l8)], 131.58 [C(15), C(l9)], 153.15 [C(8a)], non-protonated and vinylic carbons 
[108.86, 132.41, 142.77, 143.13]. Anal for C21H21NO: C, 83.16; H, 6.97; N, 4.17. 
Found: C, 83.24 H, 7.16; N, 4.48. 
(El-4-[2-Methyl-2-(4.4-dimethyl-6-chrornanyl)-1-prQpenyl]-
benzaldehyde ( 60c) 
A solution of the nitrile 60b (0.20 g, 0.66 mmol) in 25 mL of dry ether under N 2 was 
stirred at room temperature in a 50-mL, three-necked, round-bottom flask equipped with a 
condenser, and a solution of diisobutylaluminium hydride (DffiAL-H) in hexane (1.0 M, 
1.34 mL, 1.34 mmol) was added dropwise. When the addition was complete (2 min), the 
mixture was allowed to boil with stirring for 38 h and was then allowed to cool to room 
temperature. The resulting solution was diluted with CH30H (10 mL). Dilute H2S04 
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(5%, 25 mL) was added cautiously until the aqueous phase was acidic. This aqueous layer 
was washed with ether (2 x 25 mL). The combined organic phase and extracts were 
washed with 5% NaHC03 (2 x 50 mL), water (50 mL), and finally with brine (25 mL). 
After drying (MgS04, 30 min), the solution was evaporated to a viscous yellow oil. 
Chromatography of the oil was performed using silica gel (• 12 grams) through a vertical 
column (8 x 200 mm). Elution was effected with hexane:ethyl acetate (4:1, 200 mL). 
Concentration of the eluent gave a viscous oil which solidified upon standing in an ice bath 
for 2 h. Solution of the solid in minimum amount of hot hexane gave, upon cooling, 51 
mg (26%) of aldehyde 60c as a white crystalline material: mp 85-86oC (lit65 102-104°). 
IR (KBr) 2750 (CH=O), 1700 (C=O) cm-1; lH NMR (DCC13) 8 1.39 [s, 6 H, H(9), 
H(10)], 1.86 [m, 2 H, H(3)], 2.29 [s, 3 H, H(12)], 4.22 [m, 2 H, H(2)], 6. 77 [s, 1 H, 
C(13)], 6.88 [d, J = 9Hz, 1 H, H(8)], 7.26 [dd, J = 9Hz, J = 3Hz, 1 H, H(5)], 7.51 [d, 
J = 9 Hz, 2 H, H(15), H(17)], 7.87 [d, J = 9 Hz, 2 H, H(16), H(18)], 10.0 [s, 1 H, 
CHO]. 13C NMR (DCC13) ppm 17.88 [C(12)], 30.7 [C(4)], 31.65 [C(9) C(lO)], 37.60 
[C(3)], 63.14 [C(2)], 116.8 [C(8)], 124.56 [C(5)], 124.93 [C(7)], 129.0 [C(15), C(l9)] 
129.5 [C(l6), C(18)], 129.61 [C(l3)], 153.39 [C(8a)], 191.79 [CHO], non-protonated 
and vinyl carbons: 129.67, 131.39, 134.14, 135.50, 140.39, 145.08. Mass spectral data 
forC21H2202rnle(M+): 306.1619. Found: 306.1617. Anal.forC21H22~: C, 82.38; 
H, 7.24. Found: C, 82.17; H, 7.60. 
CE.)-4-f2-Methyl-2-(4.4-djmethyl-6-chromanyD-l-propenyll-
benzyl Alcohol (60d) 
A solution of methyl (E)-4-[2-(3,4-dihydro-4,4-dimethyl-2H-benzopyran-6-yl)-1-
propenyl] benzoate (60a 0.29 g, 0.86 mmol) in anhydrous tetrahydrofuran (2 mL) was 
added dropwise under N2 to a stirred suspension of LiA1H4 (0.04 g, 1.10 mmol) in dry 
THF in a 25-mL, three-necked, round-bottom flask equipped with a condenser. The 
mixture was heated at reflux for 8 hand, after cooling to room temperature, ethyl acetate (8 
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mL) was added to destroy residual LiAlH4. The resulting mixture was stirred for 5 min. 
The two layers were separated, and the aqueous layer was washed (ether, 2 x 25 mL). The 
combined organic layers were washed with 5% Na2C03 (50 mL), H20 (25 mL), and brine 
(25 mL). After drying (MgS04, 2 h), the organic solution was evaporated leaving a thick 
yellow oil. Chromatography of the oil using a Chromatotron with a silica gel plate ( 4 mm) 
and eluting with 80% hexane:ethyl acetate (200 mL total) gave, after concentration, a 
viscous oil which solidified upon refrigeration overnight. Dissolving this solid in a 
minimum amount of boiling hexane produced, after cooling, 65 mg (25%) of alcohol 60d 
as a white amorphous powder mp 79-8o·c (Iit65 80-81.). IR (KBr) 3060-3510 (0-H) 
cm-1. lH NMR (DCCl3) o 1.18 [s, 6 H, H(9), H(lO)], 1.86 [m, 2 H, H(3)], 1.90 [s, 1 
H, OHJ, 2.26 [s, 3 H, H(12)], 4.22 [m, 2 H, H(2)], 4.70 [s, 2 H, H(20)], 6.76 [s, 1 H, 
H(13)], 6.82 [d, J = 9 Hz, 1 H, H(8)], 7.28 [dd, J = 9 Hz, 1 H, H(7)], 7.38 [s, 4 H, 
H(15), H(16), H(18), H(19)], 7.44 [d, J =3Hz, 1 H, H(5)]. 13C NMR (DCC13) ppm 
17.56 [C(12)], 30.70 [C(4)], 31.31 [C(9), C(lO)], 37.66 [C(3)], 63.10 [C(2)], 65.18 
[C(20)], 116.70 [C(8)], 124.40 [C(5)], 124.8 [C(7)], 125.37 [C(13)], 129.6 [C(15), 
C(19)], 134.4 [C(16), C(18), 154.0 [8a]. There are other non-protonated and vinyl 
carbons which could not be distinguished. 131.22, 136.02, 137.42, 138.70, 153.04. 
Mass spectral data for C21H2402: rnfe (M+) 308.1776. Found: 308.1765. Anal. for 
C21H2402: C, 81.76; H, 7.78. Found: C, 82.05; H, 7.41. 
CEl-4-[2-(3.4-Dihydro-4.4-dirnethyl-2H-1-benzopyrau-
6-yD-1-pro.penyllbeozylarnine (60e) 
A 50-mL, flame dried, three-necked, round-bottom flask was equipped with a teflon-
coated stirring bar, an addition funnel, a condenser fitted with a bubbler for a nitrogen 
outlet, and a rubber septum connected to a nitrogen inlet. The flask was charged with 
LiAIH4 (73 mg, 1.80 mmol) and 9.5 mL of dry THF. Dropwise addition of a solution of 
nitrile 60b (0.315 g, 1.04 mmol) in 6 mL of dry TIIF was effected with constant stirring. 
87 
The mixture was stirred at room temperature for 8 h. To this was added about 14 mL of 
ethyl acetate to destroy the excess LiA~. A solution of 5% HCl (5 mL) was then added, 
and resulting mixture was stirred for 5 min. The layers were separated, and the aqueous 
layer was washed with ether (2 x 30 mL). The combined organic layers were washed with 
5% aqueous NaHC03 (2 x 30 mL), H 20 (30 mL), and saturated NaCl solution (50 mL). 
The combined organic layers were dried over anhydrous magnesium sulfate and 
concentrated in vacuo to give yellow oil, which was passed through 15 g of silica gel 
[column, 8 x 200 mm]. The product was eluted with 250 mL of ethyl acetate:ethanol (1:1). 
Concentration of the eluent gave a viscous oil from which a yellow solid was obtained after 
refrigeration for 4 days. Recrystallization (hexane) gave 68 mg (21 %) of 60e as a pale 
yellow solid: mp 103-105oC; IR (KBr) 3300-3500 cm-1 (primary NH2); lH NMR 
(DCCl3) o 1.36 [s, 6 H, H(9), H(lO)], 1.85 [m, 2 H, H(3)], 2.20 [s, 3 H, H(12)], 3.95 
[s, 2 H, C(20)], 4.20 [m, 2 H, H(2)], 4.42 [brs, 2 H, NHv, 6.66 [s, 1 H, H(13)], 6.75 
[d, J =9Hz, 1 H, H(8)], 7.17 [dd, J =9Hz, J =3Hz, 1 H, H(7)], 7.26 [d, 1 H, H(5)], 
7.31-7.38 [m, 4 H, Ar-H]; 13C NMR (DCCI3) ppm 17.57 [C(12)], 30.72 [C(4)], 31.12 
[C(9), C(lO)], 37.72 [C(3)], 43.60 [C(20)], 63.13 [C(2)], 116.75 [C(8)], 124.42 [C(5)], 
124.82 [C(7)], 125.40 [C(13)], 127.69 [C(15), C(19)], 129.47 [C(16), C(18)], 153.14 
[C(8a)], nonprotonated and vinylic carbons [127.94, 131.26, 136.01, 137.58, 138.04]; 
mass spectral data for C21H2sNO: m/e (M+) 307.1936; found 307.1948. 
(E)-4-[2-(3.4-Dihydro-4.4-dimethyl-2H-1-benzopyran-
6-yl)-1-pro.penyllacetophenone (60t) 
To a 100-mL, flame-dried, three-necked, round-bottom flask equipped with a 
mechanical stirrer, an addition funnel with rubber septum connected to nitrogen inlet, and a 
dry-ice condenser was added 0.06 g (2.65 g at) of magnesium turnings and 0.5 mL of dry 
ether. Dropwise addition of a solution of 0.15 mL (2.40 mmol) of methyl iodide in about 1 
mL of dry ether was effected with constant stirring. After complete addition of the methyl 
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iodide solution, the reaction mixture was stirred for 25 min at room temperature. The 
reaction mixture was then cooled to o·c by using an ice bath, and a solution of nitrile 60b 
(0.44 g, 1.45 mmol) in 35 rnL of dry ether was added over a period of 2 min. When the 
addition was complete, the reaction mixture was boiled for 24 h. After cooling to room 
temperature, the mixture was poured into a 250 mL beaker containing ice and produced a 
turbid solution. To this solution was added about 10 mL of 5% HCl solution and the new 
mixture was boiled overnight to give two separate layers. The organic layer was separated 
and the water layer was washed with ether (2 x 50 mL). The combined organic layers were 
washed with dil. NaHC03 (2 x 50 mL), 50 mL of H20, and 50 mL of saturated NaCl 
solution. The combined ethereal layers were dried over anhydrous magnesium sulfate (2 
h), filtered and concentrated in vacuo to give thick yellow oil. Chromatography of oil was 
performed using silica gel (15 g) through vertical column (8 x 200 mm). Elution was 
effected with benzene (150 mL). Concentration of the eluent gave a viscous oil which 
solidified upon refrigeration overnight The crude solid was recrystallized (95% ethanol) to 
afford 0.102 g (22%) of 60f as a pale yellowish white crystalline solid: mp 88-89oC (lit65 
109-llO.C). IR (KBr) 1690 cm-1 (C=O); lH NMR (DCC13) a 1.39 [s, 6 H, H(9), 
H(lO)], 1.87 [m, 2 H, H(3)], 2.28 [s, 3 H, H(12)], 2.62 [s, 3 H, H(21)], 4.22 [m, 2 H, 
H(2)], 6.75 [s, 1 H, H(13)], 6.80 [d, J = 9 Hz, 1 H, H(8)], 7.26 [dd, 1 H, H(7)], 7.28 
[d, J = 3 Hz, 1 H, H(5)], 7.28 [d, J = 3 Hz, 1 H, H(5)], 7.44 [d, J = 9Hz, 2 H, H(15), 
H(19)], 7.96 [d, J =9Hz, 2 H, H(16), H(18)]; 13C NMR (DCCl3) ppm 17.79 [C(12)], 
26.57 [C(21)], 30.70 [C(4)], 31.06 [C(9), C(lO)], 37.61 [C(3)], 63.12 [C(2)], 116.82 
[C(8)], 124.52 [C(5)], 124.89 [C(7)], 124.99 [C(13)], 128.28 [C(l5), C(l9)], 129.18 
[C(16), C(l8)], 153.43 [C(8a)], 197.68 [C(20)], nonprotonated and vinylic carbons 
[131.33, 134.73, 135.61, 139.73, 143.63]; Mass spectral data for C22H2402: rnle (M+) 





A solution of n-butyllithium in hexane (1.55 M, 1.23 mL, 1.88 mmol) was added 
dropwise under N2 to a stirred suspension of phosphonium salt 67 (1 g, 1.88 mmol) in 
dry ether (20 m.L) in a 50-mL, three-necked, round-bottom flask. The resulting solution 
was cooled to -78·c, and a solution of5-acetoxymethyl-2-furaldehyde (70, 0.316 g, 1.88 
mmol) was added over a period of 1 min. The solution was stirred for a few min at -78•c 
and then at room temperature for 24 h. The mixture changed from reddish-brown to a pale 
brown color. After 24 h, the reaction mixture was filtered. The resulting solid was 
washed with 45 mL of ether (anhydrous), and the ftltrate was concentrated to give a yellow 
oil. This yellow oil was refrigerated for 24 h and became a dark yellow solid. This solid 
was passed through 20 g of silica gel [column, (8 x 200 mm)]. The product was eluted 
with 300 mL ofhexane:ethyl acetate (4:1). Concentration of the eluent gave a viscous oil 
from which a yellow solid was obtained after keeping the oil in an ice bath at o·c for 5 h. 
Recrystallization (hexane) gave 0.12 g (19%) of 60g as a white crystalline solid: mp 80-
81 ·c. lH NMR (DCCI3) a 1.37 [s, 6 H, H(9), H(lO)], 1.85 [m, 2 H, H(3)], 2.1 [s, 3 H, 
H(20)], 2.36 [s, 3 H, H(12)], 4.20 [m, 2 H, H(2)], 5.08 [s, 2 H, H(18)], 6.31 [d, 1 H, J 
= 3Hz, H(16)], 6.46 [d, 1 H, J = 3 Hz, H(5)], 6.53 [s, 1 H, H(13)], 6.77 [d, 1 H, J = 9 
Hz, J =3Hz, H(8)], 7.21 [dd, 1 H, H(7)], 7.39 [d, 1 H, H(15)]; 13C NMR (DCC13) ppm 
18.24 [C(12)], 20.94 [C(20)], 30.69 [C(4)], 31.06 [C(9), C(lO)], 37.63 [C(3)], 58.31 
[C(18)], 63.11 [C(2)], 109.54 [C(16)], 114.15 [C(15)], 116.8 [C(8)], 124.36 [C(5)], 
124.77 [C(7)], 170.69 [C(19)], nonprotonated and vinylic carbons [131.3, 135.6, 136.9, 
147.7, 153.3, 154.64], mass spectral data for C21H2404: rnle (M+) 340.16745; Found 




In a 200-mL, three-necked, round-bottom flask equipped with nitrogen inlet, reflux 
condenser, bubbler for nitrogen outlet, and magnetic stirrer were mixed ester 60a (1.29 g, 
3.84 mmol) and selenium dioxide (1.28 g, 11.52 mmol) in 75 mL of 95% ethanol. The 
reaction mixture was stirred at reflux for 24 h, and then the solution was allowed to cool to 
room temperature. The solution was filtered through cotton plug to remove elemental 
selenium which was formed during the course of the reaction. The solution was 
concentrated under reduced pressure to a volume of 15 mL and this solution was diluted 
with 75 mL of ether. The new solution was washed with saturated NaHC03 solution (2 x 
50 mL), H20 (50 mL), and saturated NaCl solution (50 mL). After drying (MgS04, 2 h), 
the organic solution was evaporated leaving a yellow oil. Chromatography of the oil was 
performed using silica gel(=- 15 grams) through a vertical column (8 x 200 mm). Elution 
was effected with hexane:ethyl acetate (4:1, 200 mL). Concentration of the eluent gave a 
viscous oil which solidified upon refrigeration for 5 days. The off white solid obtained 
was recrystallized (absolute ethanol) to give 0.202 g (15%) of 60k as a pale yellow 
crystals: mp 85-86°C. IR (KBr) 3150-3600 (0-H) cm-1, 1740 (C==O) cm-1 , 1H NMR 
(DCC13) a 1.18 [s, 6 H, H(9), H(lO)], 1.62 [t, 1 H, OHJ, 1.81 [m, 2 H, H(3)], 3.9 [s, 1 
H, H(21)], 4.2 [m, 2 H, H(2)], 4.5 [d, 2 H, H(l2)], 6.7 [s, 1 H, H(13)], 6.79 [d, J == 9 
Hz, 1 H, H(8)], 6.96 [dd, J == 9 Hz, J = 3 Hz, 1 H, H(7)], 7.06 [d, J = 3 Hz, 1 H, H(5)], 
7.1 [d, J =9Hz, 2 H, H(15), H(19)], 7.79 [d, J =9Hz, 2 H, H(16), H(18)]. 13C NMR 
(DCCl3) 29.33 [C(4)], 29.68 [C(9), C(lO)], 36.27 [C(3)], 50.83 [C(21)], 61.98 [C(l2)], 
66.77 [C(2)], 116.24 [C(8)], 123.46 [C(5)], 125.69 [C(7)], 126.73 [C(13)], 127.91 
[C(15), C(19)], 128.08 [C(16), C(18)], 152.32 [C(8a)], 165.81 [C(20)], nonprotonated 
and vinylic carbons [126.91, 127.99, 130.95, 140.77, 142.86]; UV (EtOH) Amax 285 nm 
(E 1.7 x 104), 302 (1.5 x 104); mass spectral data for C22H2404: m/e (M+) 352.16745; 
found 352.1673. Anal for C22H2404: C, 75.03; H, 6.87. Found C, 74.84; H, 7.00. 
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The presence of the (Z)-isomer 60h as a slightly impure oil from chromatography was 
indicated by the following lH NMR signals: (DCCl3) ~ 1.38 [2, 6 H, H(9), H(lO)], 1.62 
[t, 1 H, OH], 1.86 [m, 2 H, H(3), 3.9 [s, 1 H, H(21)], 4.2 [m, 2 H, H(2)], 4.7 [d, 2 H, 
H(12)], 6.8 [s, 1 H, H(13)], 6.9 [d, J =9Hz, 1 H, H(8)], 7.3 [dd, J = 9Hz, J = 3 Hz, 1 
H, H(7)], 7.5 [d, j = 3 Hz, 1 H, H(5)], 7.5 [d, J = 9 Hz, 2 H, H(15), H(19)], 8.0 [d, J = 
9Hz, 1 H, H(16), H(18)]; UV (EtOH) A.max 241 nm (e 1.7 x 104), 314 (2.4 x 104) 
CEl-4-[2-(3.4-Dihydro-4.4-dimethyl-2H -1-benzop,yran-
6-yl)-3-bydrox,y-1-pmpenyllbenzoic Acid (601) 
A 15-mL, flame dried, two-necked, round-bottom flask was equipped with a teflon-
coated stirring bar, a condenser, bubbler, and a rubber septum connected to a nitrogen 
inlet. The flask was charged with ester 60k (60 mg, 0.171 mmol) and a solution ofNaOH 
(0.06 g, 1.52 mmol) in 95% ethanol (2 mL) and H20 (3 mL). The reaction mixture was 
heated at reflux for 9 h. Mter cooling slowly toRT( .. 1 h), the solution was acidified 
(litmus) with cone. HCl (pH .. 2.0). The resulting off-white solid was filtered, washed 
with water, and air dried. Recrystallization (absolute C2H50H) gave 32 mg (56%) of acid 
601 as an off-white solid: mp 198-199oC; IR (KBr) 2400-3500 (OH), 1680 cm-1 (C=O); 
lH NMR (DMSO d6) ~ 1.1 [s, 6 H, H(9), H(10)], 1.78 [m, 2 H, H(3)], 2.52 [s, 1 H, 
OH], 4.14 [m, 2 H, H(2)], 4.26 [brs, 2 H, H(12)], 6.68 [s, 1 H, H(13)], 6.72 [d, J = 9 
Hz, 1 H, H(8)], 6.93 [dd, J = 9 Hz, J = 3 Hz, 1 H, H(7)], 7.02 [d, J = 3 Hz, 1 H, H(5)], 
7.09 [d, J = 9Hz, 2 H, H(15), H(19)], 7.71 [d, J = 9Hz, 2 H, H(l6), H(18)]; 13NMR 
(DMSO d6) 29.91 [C(4)], 30.33 [C(9), C(lO)], 36.70 [C(3)], 62.40 [C(2)], 65.37 
[C(l2)], 116.7 [C(8)], 122.34 [C(5)], 126.38 [C(7)], 128.04 [C(13)], 128.60 [C(15), 
C(19)], 128.89 [C(16), C(18)], 152.64 [C(8a)], 167.0 [C(20)], nonprotonated and vinylic 
carbons (127.54, 129.73, 131.52, 141.89, 145.26); mass spectral data for C21H2204: 
m/e (M+) 338.15180; found 338.1515. The elemental analysis indicated a slight impurity. 
Attempted Prnparation of Lactone 72: Attempted Oxidation 
of CC2) in 60a with Ru04 in CCl41H~ 
92. 
To a solution containing Ru02 • x H20 (200 mg, 1.5 mmol, Alfa Products, Denvers, 
Massachusetts 01923) in 25 mL of CC14 cooled to -5 to -12°C (ice/Nacl) was added a 
solution of Nai04 (1.70 g, 7.98 mmol) in 25 mL of H20 in a 100-mL, single-necked, 
round-bottom flask. Vigorous stirring of the two layers was continued for 1 h. The CC14 
layer containing Ru04 was separated, filtered through glass wool, and collected in a 50-
mL, three-neck, round bottom flask. This yellow solution was cooled to -4 oC and to this 
solution was slowly added a solution of ester 60a (0.336 g, 1 mmol) in 2 mL of CC14 via a 
syringe over a period of 3 min. At the end of the addition, the reaction mixture changed 
color from a clear yellow to an off-yellow with a black suspension present. The reaction 
mixture was then allowed to warm slowly to room temperature and was stirred for 48 h. 
The precipitated Ru02 was removed by filtration through celite, and the solvent was 
removed in vacuo to afford the yellow oil. This yellow oil was passed through silica gel 
[28 g, column was 8 x 200 mm]. The product was eluted with 150 mL of hexane:ethyl 
acetate (9:1) followed by ethyl acetate:ethanol (1:1). Fractions 1-8 contained ester 60a and 
fractions 17-22 contained acid 71 in approximately equivalent amounts. Crude 60a had 
the following data. lH NMR (DCCl3) a 1.38 [s, 6 H, H(9), H(10)], 1.9 [m, 2 H, H(3)], 
2.3 [s, 3 H, H(12)], 3.89 [s, 3 H, H(21)], 4.21 [m, 2 H, H(2)], 6.78 [s, 1 H, H(13)], 
6.84 [d, J =9Hz, 1 H, H(8)], 7.3 [dd, J =9Hz, J =3Hz, 1 H, H(7)], 7.4 [d, J =3Hz, 
1 H, H(5)], 7.49 [d, J = 9 Hz, 2 H, H(15), H(19)], 8.6 [d, J = 9 Hz, 2 H, H(16)], 
H(18)]. The lH NMR spectrum was superimposable on that from a known sample. Data 
for 71 are mp 201-203oC (1it93 194-196°C). 1 NMR (DCC13) a 4.0 [s, 3 H, OCH.l], 7.3-
8.4 [m, 4 H, Ar-H]. Rr values (TLC) were 0.56 for 60a and 0.10 for 71 (the solvent 
system was 80% hexane:ethyl acetate). 
Attempted Pre.paration of Lactone 72: Attempted Oxidation 
of CC2> in 60a with Ru04 in CH3Q:iLH~/CCl4 
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A 25-rnL, two-necked, round-bottom flask was equipped with a power stirrer and a 
glass stopper. The flask was charged with 2 rnL of carbon tetrachloride, 2 rnL of 
acetonitrile, 3 rnL of H20, ester 60a (0.336 g, 1.0 mmol), and NaiO 4 (0.641 g, 3 mmol). 
This mixture was stirred for 10 min. To the biphasic solution was added Ru02 • x H20 
(3.3 mg, 2.2 mmol %). The entire mixture was stirred vigorously for 5 h at room 
temperature. Then 10 rnL of CH2Cl2 was added, and the phases were separated. The 
upper aqueous phase was extracted with CH2Cl2 (3 x 30 rnL). The combined organic 
extracts were dried (MgS04, 30 min), flltered, and concentrated in vacuo. The resulting 
residue was diluted with 20 rnL of ether, flltered through a celite pad, and concentrated to 
give an off-white solid. Chromatography of this solid was performed using silica gel (18 
g) through a vertical column (8 x 200 mm). Elution was effected with 80% hexane:ethyl 
acetate (150 rnL). Concentration of the fractions 1-11 and 14-21 revealed the presence of 
ester 60a and aldehyde 68, respectively. Crude 60a had the following data. lH NMR 
(DCC13) a 1.4 [s, 6 H, H(9), H(10)], 1.9 [m, 2 H, H(3)], 2.3 [s, 3 H, H(12)], 3.90 [s, 3 
H, H(21)], 4.21 [m, 2 H, H(2)], 6.78 [s, 1 H, H(13)], 6.84 [d, J = 9 Hz, 1 H, H(8)], 
7.28 [dd, J = 9 Hz, J = 3 Hz, 1 H, H(7)], 7.4 [d, J = 3 Hz, 1 H, H(5)], 7.49 [d, J = 9 
Hz, 2 H, H(15), H(19)], 8.6 [d, J =9Hz, 2 H, H(16), H(18)]. The lH NMR spectrum 
was superimposable on that from a known sample. Data for crude ester 68 was as 
follows. lH NMR (DCC13) ~ 3.38 [s, 3 H, OCH.3.], 7.80-8.40 [m, 4 H, Ar-H], 10.10 [s, 
1 H, CHO]. The lH NMR spectrum was superimposable on that from a knoWo sample. 
Attempted Preparation of Lactone 72: Attempted Oxidation 
of C(2> in 60a with KI04 in CCl4/CH3lliLHil 
A 200-rnL, three-necked, round-bottom flask was equipped with a mechanical stirrer. 
The flask was charged with 30 mL ofCCl4, 30 mL ofCH3CN, 45 rnL of H20, KI04 (1.0 
94 
g, 4.2 mmol) and K2C03 (78 mg, 0. 79 mmol). This reaction mixture was stirred for 5 
min. To this biphasic solution was added ester 60a (0.336 g, 1 mmol) and Ru02 • x H20 
( 4 mg, 2.6 mmol % ), and the entire mixture was stirred vigorously for 6 h at RT. Then 15 
mL of CH2Cl2 was added, and two phases were separated. The upper aqueous phase was 
extracted with CH2Cl2 (3 x 45 mL). The combined organic extracts were dried (MgS04), 
30 min), filtered, and concentrated in vacuo. The resulting residue was diluted with 30 mL 
of ether, flltered through a celite pad, and concentrated to give oil. Chromatography of this 
solid was performed using silica gel (18 g) through vertical column (8 x 200 mm). Elution 
was effected with 80% hexane: ethyl acetate (100 mL). Concentration of the fractions 1-9 
adn 12-18 showed the presence of liquid ketone 65 and aldehyde 68. Crude 65 had the 
following data. lH NMR (DCCl3) o 1.38 [s, 6 H, (CH.3.)2C], 4.28 [m, 2 H, CH20], 6.82 
[d, 1 H, H(8)], 7.71 [dd, 1 H, H(7)], 7.99 [d, 1 H, H(5)]. The lH NMR spectrum was 
superimposable on that from a known sample. Data for crude 68 was as follows; lH 
NMR (DCCl3) o4.0 [s, 3 H, OCHJ.], 7.80-8.32 [m, 4 H, Ar-H], 10.10 [s, 1 H, CHO]. 
the lH NMR spectrum was superimposable on that from a known sample. 
Attempted Pre.paration of Lactone 72: Attempted Oxidation 
of CC2) in 60a with ZnCr2,07..! .lli20 in CH2,Cb 
A 50-mL, three-necked, round-bottom flask was equipped with teflon-coated magnetic 
stirrer, and condenser. The flask was charged with ester 60a (0.18 g, 0.52 mmol) and 10 
ml of dry CH2Cl2. To this was added ZnCr207 • 3H20 23 (1.06 g, 3.12 mmol) and 
reaction mixture was stirred at RT for 48 h. The mixture was flltered and the filter cake 
was washed with CH2CI2 (20 mL). The filtrates were combined, and evaporated to give 
pale yellow liquid. The resulting liquid was chromatographed on silica gel (18 g) [column 
was 8 x 200 mm] and elutions were carried out with 150 mL of 80% hexane:ethyl acetate. 
Fractions with the same Rf values were mixed together and, upon concentration, showed 
the presence of ketone 65 and aldehyde 68. Crude 65 had the following data. 1 H NMR 
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(DCCl3) 8 1.38 [s, 6 H, (CH3)2C], 4.28 [m, 2 H, CHzO], 6.82 [d, 1 H, H(8)], 7.71 [dd, 
1 H, H(7)], 7.99 [d, 1 H, H(5)]. The lH NMR (DCCI3) o 4.00 [s, 3 H, OCH1], 7.80-
8.32 [m, 4 H, Ar-HJ, 10.10 [s, 1 H, CHO]. The lH NMR spectrum was superimposable 
on that from a known sample of 65. 
Attempted Pre.Paration of Lactone 72: Attempted Oxidation 
of CC2) in 60a with Pyridinium Chlorochromate 
iru:HzQz 
A solution of the ester 60a (0.336 g, 1 mmol) in 5 mL of dry CHzCl2 was placed 
under Nz in a 50-mL, three-necked, round-bottom flask equipped with a magnetic stirrer 
and a condenser. To this was added pyridinium chlorochromate (PCC) (0.645 g, 3 mmol, 
Aldrich Chemical Co., Milwaukee, Wisconsin 53233). The reaction mixture was heated at 
reflux for 24 h. The cooled mixture was added through a silica gel (25 g) column [8 x 200 
mm]. Elutions were carried out with 80% hexane:ethyl acetate (150 mL). Fractions with 
same Rr values were mixed together and, upon concentration, showed the presence of 
ketone 65 and aldehyde 68. Crude 65 had the following data. lH NMR (DCCI3) o 1.38 
[s, 6 H, (CHJ)zC], 1.84 [m, 2 H, CH.iJ, 2.52 [s, 3 H, CH3,C], 4.28 [m, 2 H, CHzO], 
6.84 [d, 1 H, H(8)], 7.71 [dd, 1 H, H(7)], 7.99 [d, 1 H, H(5)]. The lH NMR spectrum 
was superimposable on that from a known sample. Data for crude 68 were as follows: lH 
NMR (DCCl3) o 4.00 [s, 3 H, OCHJ,], 7.80-8.32 [m, 4 H, Ar-H], 10.10 [s, 1 H, CHO]. 
The 1 H NMR spectrum was superimposable on that from a known sample of 68. 
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PFT X CW _ ; Solvent: DCCl3 SF: 299.944 Mllz; WC: 2999.4 Hz; T:RT °C; NT: 16 
Size: 8 K; Pl-7/RF: 5.0 ps/dB; TO: 0 liz; FB:_ liz; Lock: 2H ;Dl,DS: 0.500 s • 
DC: N ; Gated Off:A or D ; DO: 0 Hz; RF(Power): 10 l-7/dB; NB\-1: 200 liz; LB: 0 Hz. I-' 0 
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13c NMR Spectrum of 60a 
PFT ~ CW Solvent: DCCl3 SF: 75.429 Mllz; WC: 15085.9 Hz; T: RT °C; NT: 192 
Size : 16 K; Pt-1/RF: 12.0 ~s/dB; TO: 1000 Hz; FB:- Hz; Lock: 2H ; Dl,D5: 4.000 s. 
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Off Resonance 13C NMR Spectrum of 60a 
Solvent: DCCl3 . SF: 75.429 MHz; we: 1508.9 Hz; 
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PlJ/RF: 12.0 J.Js/dB; TO: 1000 Hz; FB: 
-
Hz; 
Gated Off:A or D ; DO: -2500 Hz; RF(Power): 20 U/dB; 
.. 0 20 0 t3c 
2 1 o 111 
T: RT oc; NT: 416 
Lock: zH ; Dl,D5: 4.000 s. 
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1 H NMR Spectrum of 60b 
PFT X CW . Solvent: DCCla . SF:299.944 MIIz; we: 2999.4 Hz; 
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• • 
Size: 8 K; Pl-1/RF: 5.0 ~s/dB; TO: 0 Hz; FB: 
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Hz; 
DC: N ; Gated Off;A or D ; DO: 0 Hz; RF(Power); 15 U/dB; 
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T; RT OC; NT: 8 
Lock: 2H ;Dl,D5: 0 
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13c NMR Spectrum of 60b 
PFT !.- CW . Solvent: DCCl3 ; SF: 75.429 Mllz; WC: 15085.9Hz; T: RT OC; NT: 308 • 
Size: 16K; PV/RF: 12.0 IJS/dB; TO: 1000 liz; FB: - Hz; Lock: 2H ; Dl,D5: 5.000 s. 
DC: Y Gated Off:A or D ; DO: Hz; RF(Power): U/dB; Hz. '""" ; NBW: liz; LB: 0 
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13 Off Resonance. C NMR Spectrum of 60b 
PFT _]: CW Solvent: DCCl3 SF: 75.429 MHz; WC: 15085.9 Hz; T: RT 
Size: 16 K; P1.J/RF: 12.0 )Js/dB; TO: 1000 liz; FB: 
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Hz; Lock: H 
DC: Y Gated Off:A or D ; DO: Hz; RF(Power): U/ dB; NB\.J: 
20 o 13c 
0 111 
°C; NT: 132 
; Dl,D5: 5.000 s . 
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1H NMR Spectrum of 60c 
SF: 299.944 MHz; WC: 2999.4 Hz; 
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0 Hz; RF(Power): 15 U/dB; 
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13c NMR Spectrum of 60c 
PFT X CW Solvent: DCC1 3 SF: 75.429 Mllz; WC: 15085.911z; T: RT °C; NT: 176 
Size: 20 K; PH'/RF: 12.0 IJs/dB; TO: 1000 liz; FB: - Hz; Lock: 2H ;Dl,D5: 4.000 s. 












PFT ~ CW 
9 8 7 6 5 .. 3 
Off Resonance 13C NMR Spectrum of 60c 
Solvent: DCCl3 SF: 75.429 MHz; WC: 15085.9 Hz; T: RT 
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Size: 20 K; Plol/RF: 12.0 JJs/dB; TO: 1000 Hz; FB: liz; Lock: 2 11 
20 o I3c 
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1H NMR Spectrum of 60d 
PFT X CW . Solvent: DCC1 3 . SF: 299.944 MHz; WC:2999.4 Hz; T• RT oc; NT: 12 • t . 
Size: 12 K; P'.J/RF: 5.0 IJS/dB; TO: 0 Hz; FD: - Hz; Locks 2H ; Dl,D5: 0 s • 
DC: N ; Gated Off:A or D i DO: 0 Hz; RF{Power): 15 \~/dB; NBW: 200 Hz; LB: 0.500 Hz, ..... ..... 
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13c NMR Spectrum of 60d 
PFT X CW Solvent: DCCb SF:75.429 MHz; WC: 15085.9 Hz; T: RT °C; NT: 220 
Size: 16 K; PW/RF: 12.0 lJs/dB; TO: 1000 Hz; FB: - Hz; Lock: 2 H ; Dl,D5: 4.000 s • 
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13 Off Resonance C NMR Spectrum of 60d 
Solvent: DCC1 3 SF: 75.429 MHz; WC: 15085.911z; T: RT 
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Size: 16 K; PI-.1/RF: 12.0 IJs/dB; TO: 1000 liz; FB: Hz; Locks 2H 
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°C; NT: 528 
; Dl,D5: 4.000 s. 
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1H NMR Spectrum of.60e 
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13C NMR Spectrum of 60e 
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1 H NMR Spectrum of 60g 
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PFT _xcw Solvent:ncc1 3 ; SF: 75.429 MHz; WC: 15085.9Hz; T: RT °C; NT: 800 
Size: 20 K; PW/RF: 12.0 J.Js/dB; TO: 1000 Hz; FB: liz; Lock: 2u ; Dl.D5: 4.000 
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Off Resonance 13C NMR Spectrum of 60g 
PFT ~ CW . Solvent: DCCl3 ; SF: 75.429 MHz; WC: 15085.9 Hz; T• RT oc; NT: 176 
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Size: 20 K; PI~/RF: 12.5 J-ls/dB; TO: 1000 Hz; FB: - Hz; Lock: zH ; Dl,D5: 4.000 s. 
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1H NMR Spectrum of 60i 
PFT X CW Solvent: DCC1 3 SF: 299.944 Mllz; WC: 2999.4 Hz; T: RT °C; NT: 16 
Size: 12 K; Pl-1/RF: 5.0 ps/dB; TO: 0 Hz; FB: - Hz; Lock: 2H ;Dl,DS: 0 
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13C NMR Spectrum of 60i 
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Off Resonance 13C NMR Spectrum of 60i 
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1H NMR Spectrum of 60j 
PFT X CW Solvent: DCC1 3 SF: 299.944 Mllz; WC: 2999.4 Hz; T: RT °C; NT: 16 
Size: 8 K; PH/RF: 5.0 IJS/dB; TO: 0 Hz; FB: Hz; Lock: 2 H ; Dl,DS: 0.500 s . 
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Off Resonance 13C NMR Spectrum of 60j 
PFT X CW Solvent: DCC1 3 SF: 75.429 Mllz; WC: 15085.9 Hz; T: RT °Ci NT: 720 
Size: 16K; PV/RF: 14.0lJs/dB; TO: 1000 liz; FB: liz; Lock: 2 H i Dl,D5: 4.000 s. 
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1 H NMR Spectrum of .60~ 
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13c NMR Spectrum of 60k 
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1H NMR Spectrum of 65 
SF: 299.944 MHz; we: 2999.4 Hz; 
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13C NMR Spectrum of 67 
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